書籍詳細

1章 高齢者の機能低下の病態

P.9 掲載の参考文献

• 1. 中橋 毅, 森本茂人. 老化の機序. 荻原俊夫編. 老年医学. 東京: 朝倉書店; 2003. p.6-15.

• 2. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell stains. Exp Cell Res 1961; 25: 585-621.

• 3. Harley CB, et al. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-60.
  pubmed

• 4. Vaziri H, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52: 661-7.
  pubmed

• 5. Kallman FG, Sander G. Twin studies on ageing and longevity. J Hered 1948; 39: 349-57.

• 6. Yu CE, et al. Positional cloning of the Werners syndrome gene. Science 1996; 272: 258-62.
  pubmed

• 7. Schachter F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6: 29-32.
  pubmed

• 8. Gensler HL, Bernstein H. DNA damage as the primary cause of aging. Q Rev Biol 1981; 56: 279-303.
  pubmed

• 9. Bjorksten J, Tenhu H. The crosslinking theory of aging added evidence. Exp Gerontol 1990; 25: 91-5.
  pubmed

• 10. Shephard RJ, Shek PN. Cancer, immune function and physical activity. Can J Appl Physiol 1995; 20: 1-25.
  pubmed

• 11. 廣川勝いく. 老化と免疫. 日老医誌2003; 40: 543-52.

• 12. Silver AJ, et al. Effect of aging on body fat. J Am Geriatr Soc 1993; 41: 211-3.
  pubmed

• 13. 大道正英ほか. 女性更年期の病態と対策. 綜合臨床2003; 52: 309-19.

• 14. 鈴木隆雄. 骨・関節の老化. 臨床と研究2005; 82: 909-14.

• 15. 中村利孝. 骨粗鬆症の治療と対策. 臨床と研究2005; 82: 921-5.

• 16. Young A, Skelton DA. Applied physiology of strength and power in old age. Int J Sports Med 1994; 15: 149-51.
  pubmed

• 17. 久野譜也. 加齢に伴う骨格筋の退行性変化. 医学のあゆみ2000; 193: 613-6.

• 18. 小林寛道. 身体活動と加齢. 日本臨牀2000; 58: 283-9.

• 19. 長瀬隆英. 加齢と肺機能の変化. 呼吸と循環2002; 50: 665-8.

• 20. Chan ED, Welsh CH. Geriatric respiratory medicine. Chest 1998; 114: 1704-33.
  pubmed

• 21. Seals DR, et al. Exercise and aging: Autonomic control of the circulation. Med Sci Sports Exerc 1994; 26: 568-76.
  pubmed

• 22. Fagard R, et al. Age and the hemodynamic response to posture and to exercise. Am J Geriatr Cardiol 1993; 2: 23-40.
  pubmed

• 23. Tsutsui Y, et al. Cardiovascular responses to lower body negative pressure in the elderly: Role of reduced leg compliance. Gerontology 2002; 48: 133-9.
  pubmed

• 24. 佐藤昭夫, 堀田晴美. 神経系の加齢変化. 折茂 肇編. 新老年学. 第2版. 東京: 東京大学出版会; 1999. p.125-43.

• 25. Salthouse TA, et al. Investigation of student status, background variables, and feasibility of standard tasks in cognitive aging research. Psychol Aging 1988; 3: 29-37.
  pubmed

• 26. Moller MB. Hearing in 70 and 75 year old people: Result from a cross-sectional and longitudinal population study. Am J Otolaryngol 1981; 2: 22-9.
  pubmed

• 27. Mizushima T, et al. Muscle sympathetic nerve activity during cold pressor test in patients with cerebrovascular accidents. Stroke 1998; 29: 607-12.
  pubmed

• 28. Collins KJ, et al. Functional changes in autonomic nervous responses with ageing. Age Ageing 1980; 9: 17-24.
  pubmed

• 29. Hellon RF, Lind AR. Observations on the activity of sweat glands with special reference to the influence of aging. J Physiol 1956; 133: 132-44.

• 30. Iwase S, et al. Age-related change of sympathetic outflow to muscle in humans. J Gerontol 1991; 46: M1-5.
  pubmed

• 31. Nakamura T, et al. Muscle sympathetic nerve activity during isometric exercise in patients with cerebrovascular accidents. Arch Phys Med Rehabil 2005; 86: 436-41.
  pubmed

• 32. Tajima F, et al. Renal and endocrine responses in the elderly during head out water immersion. Am J Physiol 1988; 254: R977-83.
  pubmed

• 33. Lenton EA, et al. Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles. J Clin Endocrinol Metab 1991; 73: 1180-90.
  pubmed

• 34. Utsuyama M, et al. Age-influence on the thymic capacity to promote differentiation of T cells: Induction of different composition of T cell subsets by aging thymus. Mech Ageing Dev 1991; 58: 267-77.
  pubmed

• 35. Hirokawa K. Autoimmunity and aging. Concepts Immunopathol 1985; 1: 251-88.
  pubmed

P.16 掲載の参考文献

• 1. Thewlis MW. The Care of the Aged (Geriatrics). St Louis: CV Mosby; 1954. p.208.

• 2. 江藤文夫. 過度の安静による合併症の障害学. 医学のあゆみ1981; 116: 416-22.

• 3. Hirschberg GG, et al, editors. Rehabilitation. Philadelphia: Lippincott; 1964. p.12-23.

• 4. Allen C, et al. A potentially harmful treatment needing more careful evaluation. Lancet 1999; 354: 1229-33.

• 5. 原田 孝. 廃用症候群と骨萎縮ならびに腰痛症. Monthly Book Medical Rehabilitation 2001; No 10: 22-8.

• 6. 吉永勝訓. 廃用性骨萎縮・尿路結石・異所性骨化. 日医雑誌2004; 132: 1405-8.

• 7. 赤居正美. 関節拘縮. 日医雑誌2004; 132: 1401-3.

• 8. 山田拓美. 拘縮関節可動域訓練. Monthly Book Medical Rehabilitation 2001; No 10: 14-9.

• 9. Trudel G, et al. Extent and direction of joint motion limitation after prolonged immobility: An experimental study in the rat. Arch Phys Med Rehabil 1999; 80: 1542-7.
  pubmed

• 10. Tabery JC, et al. Physiological and structural changes in the cats soleus muscle due to immobilization at different lengths by plaster casts. J Physiol 1972; 224: 231-44.

• 11. 猪飼哲夫. 筋萎縮と筋力低下. 日医雑誌2004; 132: 1397-400.

• 12. Muller EA. Influence of training and of inactivity on muscle strength. Arch Phys Med Rehabil 1970; 51: 449-62.
  pubmed

• 13. Thomason DB, et al. Protein metabolism and β-myosin heavy-chain mRNA in unweighted soleus muscle. Am J Physiol 1989; 257: 300-5.

• 14. Riley DA, et al. Rat hindlimb unloading: Soleus histochemistry, ultrastructure, and electromyography. J Appl Physiol 1990; 69: 58-66.
  pubmed

• 15. 藤井 航. 廃用と関係する嚥下能力低下. Geriatric Medicine 2002; 40: 223-7.
  Medical*Online

• 16. 美濃良夫. 皮膚の廃用症候群. Geriatric Medicine 2002; 40: 173-82.
  Medical*Online

• 17. 里宇明元. 循環器系機能低下. 日医雑誌2004; 132: 1409-13.

• 18. 岡村菊夫. 廃用により増す泌尿器科疾患. Geriatric Medicine 2002; 40: 202-8.
  Medical*Online

• 19. 石田 暉. 消化器における廃用症候群. 日医雑誌2004; 132: 1415-7.

• 20. 広瀬 健. 下肢静脈血栓症と肺塞栓. Monthly Book Medical Rehabilitation 2001; No 10: 59-65.

• 21. 江藤文夫. 廃用症候群と精神障害. 日医雑誌2004; 132: 1431-5.

P.29 掲載の参考文献

• 1. 文部科学省. 平成16年度学校保健統計調査報告書. 2005.

• 2. (財) 日本学校保健会. 児童生徒の健康状態サーベイランス事業報告書. 1996.

• 3. 山口泰雄ほか. 健康・スポーツの社会学. 東京: 建帛社; 1996.

• 4. 新井 忠. 高齢者の体力テスト. 臨床スポーツ医学1998; 15: 848-57.

• 5. 文部科学省. 新体力テスト (有意義な活用のために). 2005.

• 6. 文部科学省. 体力・運動能力調査報告書 (平成10年度~16年度). 1999-2005.

2章 骨粗鬆症

P.44 掲載の参考文献

• 1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-95.
  pubmed

• 2. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929-36.
  pubmed

• 3. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002; 359: 1841-50.
  pubmed

• 4. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359: 1761-7.
  pubmed

• 5. Fujiwara S, et al. Risk factors for hip fracture in a Japanese cohort. J Bone Miner Res 1997; 12: 998-1004.

• 6. Cummings SR, et al. Risk factors for hip fracture in white women: Study of Osteoporotic Fractures Research Group.N Engl J Med 1995; 332: 767-73.

• 7. 折茂 肇, 坂田清美. 第四回大腿骨頸部骨折全国頻度調査成績. 日本医事新報2004; 4180: 25-30.

• 8. 藤原佐枝子. 骨粗鬆症の疫学と危険因子. 日内会誌2005; 94: 614-8.

• 9. Tinetti ME, et al. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-7.
  pubmed

• 10. Tinetti ME. Clinical practice: Preventing falls in elderly persons. N Engl J Med 2003; 348: 42-9.

• 11. 折茂 肇ほか. 原発性骨粗鬆症の診断基準 (1996年改訂版). Osteoporosis Japan 1996; 4: 643-52.

• 12. Riggs BL, Melton LJ 3rd. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899-901.
  pubmed

• 13. Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med 1986; 314: 1676-86.
  pubmed

• 14. 吉村典子ほか. 骨粗鬆症の病型分類の考え方. Osteoporosis Japan 2005; 13: 839-45.
  Medical*Online

• 15. Nawata H, et al. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005; 23: 105-9.
  pubmed

• 16. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2: 389-406.
  pubmed

• 17. Lips p.Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
  pubmed

• 18. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 2001; 86: 4576-84.
  pubmed

• 19. Parfitt AM. Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994; 55: 273-86.

• 20. Duan Y, et al. Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss. J Bone Miner Res 2001; 16: 2267-75.
  pubmed

• 21. Riggs BL, Melton LJ 3rd. Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 2002; 17: 11-4.
  pubmed

• 22. Watts NB. Bone quality: Getting closer to a definition. J Bone Miner Res 2002; 17: 1148-50.
  pubmed

• 23. Bouxsein ML. Bone quality: Where do we go from here? Osteoporos Int 2003; 14 Suppl 5: 118-27.

• 24. Boyle WJ, et al. Osteoclast differentiation and activation. Nature 2003; 423: 337-42.
  pubmed

• 25. Teitelbaum SL, Ross Fp.Genetic regulation of osteoclast development and function. Nat Rev Genet 2003; 4: 638-49.
  pubmed

• 26. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-8.
  pubmed

• 27. Yoshida H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442-4.
  pubmed

• 28. McClung MR, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006; 354: 821-31.
  pubmed

• 29. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000; 289: 1508-14.
  pubmed

• 30. Ducy P, et al. The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000; 289: 1501-4.
  pubmed

• 31. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003; 423: 349-55.
  pubmed

• 32. Gong Y, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513-23.
  pubmed

• 33. Little RD, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002; 70: 11-9.
  pubmed

• 34. Boyden LM, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002; 346: 1513-21.
  pubmed

• 35. Kato M, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 2002; 157: 303-14.
  pubmed

• 36. Fujino T, et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 2003; 100: 229-34.
  pubmed

• 37. Klein RF, et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004; 303: 229-32.
  pubmed

• 38. Ducy P, et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000; 100: 197-207.
  pubmed

• 39. Takeda S, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002; 111: 305-17.
  pubmed

• 40. Schlienger RG, et al. Use of β-blockers and risk of fractures. JAMA 2004; 292: 1326-32.

• 41. Aarden EM, et al. Function of osteocytes in bone. J Cell Biochem 1994; 55: 287-99.

• 42. Burger EH, Klein-Nulend J. Mechanotransduction in bone: Role of the lacuno-canalicular network. FASEB J 1999; 13 Suppl: S101-12.

• 43. Qiu S, et al. Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone 2002; 31: 313-8.

• 44. Qiu S, et al. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res 2003; 18: 1657-63.
  pubmed

• 45. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996; 11: 1043-51.
  pubmed

• 46. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-11.
  pubmed

• 47. Gao Y, et al. Estrogen prevents bone loss through transforming growth factor β signaling in T cells. Proc Natl Acad Sci U S A 2004; 101: 16618-23.

• 48. Arron JR, Choi Y. Bone versus immune system. Nature 2000; 408: 535-6.
  pubmed

• 49. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators: Mechanisms of action and application to clinical practice. N Engl J Med 2003; 348: 618-29.
  pubmed

• 50. Van Pottelbergh I, et al. Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 2004; 89: 4949-53.

• 51. Raisz LG. Homocysteine and osteoporotic fractures: Culprit or bystander ? N Engl J Med 2004; 350: 2089-90.
  pubmed

• 52. Gilsanz V, et al. Peak trabecular vertebral density: A comparison of adolescent and adult females. Calcif Tissue Int 1988; 43: 260-2.
  pubmed

• 53. Riggs BL, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 2004; 19: 1945-54.

• 54. Seeman E. Periosteal bone formation: A neglected determinant of bone strength. N Engl J Med 2003; 349: 320-3.
  pubmed

• 55. Mosekilde L. Age-related changes in bone mass, structure, and strength: Effects of loading. Z Rheumatol 2000; 59 Suppl 1: 1-9.

• 56. Hildebrand T, et al. Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine,femur, iliac crest, and calcaneus. J Bone Miner Res 1999; 14: 1167-74.
  pubmed

• 57. Muller R. Long-term prediction of three-dimensional bone architecture in simulations of pre-, peri- and post-menopausal microstructural bone remodeling. Osteoporos Int 2005; 16 Suppl 2: S25-35.

• 58. Lindsay R, et al. Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976; 1: 1038-41.
  pubmed

• 59. Ruff CB, Hayes WC. Sex differences in age-related remodeling of the femur and tibia. J Orthop Res 1988; 6: 886-96.
  pubmed

• 60. Russo CR, et al. Aging bone in men and women: Beyond changes in bone mineral density. Osteoporos Int 2003; 14: 531-8.
  pubmed

• 61. Maggio D, et al. Age-related cortical bone loss at the metacarpal. Calcif Tissue Int 1997; 60: 94-7.
  pubmed

• 62. Garn SM. The course of bone gain and the phases of bone loss. Orthop Clin North Am 1972; 3: 503-20.
  pubmed

• 63. Duan Y, et al. Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res 2003; 18: 1766-74.
  pubmed

• 64. Duan Y, et al. The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res 2001; 16: 2276-83.
  pubmed

• 65. Jowsey J. Age changes in human bone. Clin Orthop 1960; 17: 210-8.

• 66. Riggs BL, et al. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279-302.
  pubmed

• 67. Khosla S, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 1998; 83: 2266-74.
  pubmed

• 68. Khosla S, et al. Clinical review 144: Estrogen and the male skeleton. J Clin Endocrinol Metab 2002; 87: 1443-50.
  pubmed

• 69. Gilsanz V, et al. Gender differences in vertebral body sizes in children and adolescents. Radiology 1994; 190: 673-7.
  pubmed

• 70. Gilsanz V, et al. Vertebral size in elderly women with osteoporosis: Mechanical implications and relationship to fractures. J Clin Invest 1995; 95: 2332-7.
  pubmed

• 71. Mosekilde L. Sex differences in age-related loss of vertebral trabecular bone mass and structure: Biomechanical consequences. Bone 1989; 10: 425-32.
  pubmed

P.51 掲載の参考文献

• 1. 骨粗鬆症の予防と治療ガイドライン作成委員会. 骨粗鬆症の予防と治療ガイドライン2006年版. 東京: ライフサイエ ンス出版; 2006.

• 2. Rannevik G, et al. A longitudinal study of the perimenopausal transition: Alters profits of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995; 21: 103-13.

• 3. Seltzer VL, et al. Perimenopausal bleeding patterns and pathologic findings. J Am Med Womens Assoc 1990; 45 (4) : 132-4.

• 4. Dufresne TE, et al. Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography. Calcif Tissue Int 2003; 73: 423-32.
  pubmed

• 5. Masuzawa T, et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone mass after ovariectomy. Endocrinology 1998; 139: 3022-5.

• 6. Miyaura C, et al. Increased B-lymphopoiesis by interleukin-7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency. Proc Natl Acad Sci U S A 1997; 94: 9360-5.
  pubmed

• 7. Manabe N, et al. Connection between B-lymphocyte and osteoclast differentiation pathways. J Immunol 2001; 167: 2625-31.
  pubmed

• 8. Sato T, et al. Generation of bone-resorbing osteoclasts from B220+ cells: Its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 2001; 16: 2215-21.
  pubmed

• 9. Cenci S, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α. J Clin Invest 2000; 106: 1229-37.

• 10. Roggia C, et al. Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 2001; 98: 13960-5.
  pubmed

• 11. Eghbali-Fatourechi G, et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003; 111: 1221-30.
  pubmed

P.57 掲載の参考文献

• 1. Bonjour JP, et al. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73: 555-63.
  pubmed

• 2. Matkovic V, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: Inference from a cross-sectional model. J Clin Invest 1994; 93: 799-808.

• 3. Heaney RP, et al. Peak bone mass. Osteoporos Int 2000; 11: 985-1009.
  pubmed

• 4. Lu PW, et al. Volumetric bone mineral density in normal subjects, aged 5-27 years. J Clin Endocrinol Metab 1996; 81: 1586-90.
  pubmed

• 5. Riggs BL, Melton LJ 3rd. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899-901.
  pubmed

• 6. Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med 1986; 314: 1676-86.
  pubmed

• 7. Riggs BL, Melton LJ 3rd. Clinical heterogeneity of involutional osteoporosis: Implications for preventive therapy. J Clin Endocrinol Metab 1990; 70: 1229-32.
  pubmed

• 8. Gimble JM, et al. The function of adipocytes in the bone marrow stroma: An update. Bone 1996; 19: 421-8.

• 9. Ettinger B, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282: 637-45.
  pubmed

• 10. Johnell O, et al. Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J Bone Miner Res 2004; 19: 764-72.

• 11. Riggs BL, et al. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998; 13: 763-73.

• 12. Khosla S, et al. Estrogens and bone health in men. Calcif Tissue Int 2001; 69: 189-92.
  pubmed

• 13. Bonnick SL. Skeletal anatomy in densitometry. In: Bone Densitometry in Clinical Practice. 2nd edition. New Jersey: Humana Press; 2004. p.29-67.

• 14. Melton LJ 3rd, et al. Cross-sectional versus longitudinal evaluation of bone loss in men and women. Osteoporos Int 2000; 11: 592-9.
  pubmed

• 15. 折茂 肇ほか. 原発性骨粗鬆症の診断基準 (1996年度改訂版). 日骨代謝会誌1997; 14: 219-66.

• 16. 折茂 肇ほか. 原発性骨粗鬆症の診断基準 (2000年度改訂版). 日骨代謝会誌2001; 18: 76-82.

• 17. Fujiwara S, et al. Rates of change in spinal bone density among Japanese women. Calcif Tissue Int 1998; 63: 202-7.
  pubmed

• 18. Grampp S, et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination,and diagnostic classification. J Bone Miner Res 1997; 12: 697-711.
  pubmed

• 19. Looker AC, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998; 8: 468-89.
  pubmed

• 20. Looker AC, et al. Proximal femur bone mineral levels of US adults. Osteoporos Int. 1995; 5: 389-409.
  pubmed

• 21. 萩野 浩ほか. QUS の基準値. Osteoporosis Japan 2005; 13: 31-5

P.64 掲載の参考文献

• 1. Vogel JM, Whittle MW. Bone mineral changes: The second manned Skylab mission. Aviat Space Environ Med 1976; 47: 396-400.
  pubmed

• 2. Collet P, et al. Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans. Bone 1997; 20: 547-51.

• 3. Vico L, et al. Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 2000; 355: 1607-11.
  pubmed

• 4. Watanabe Y, et al. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res 2004; 19: 1771-8.

• 5. Rittweger J, et al. Muscle atrophy and bone loss after 90 days'bed rest and the effects of flywheel resistive exercise and pamidronate: Results from the LTBR study. Bone 2005; 36: 1019-29.
  pubmed

• 6. Shackelford LC, et al. Resistance exercise as a countermeasure to disuse-induced bone loss. J Appl Physiol 2004; 97: 119-29.
  pubmed

• 7. Zerwekh JE, et al. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 1998; 13: 1594-601.

• 8. de Bruin ED, et al. Longitudinal changes in bone in men with spinal cord injury. Clin Rehabil 2000; 14: 145-52.
  pubmed

• 9. Frey-Rindova P, et al. Bone mineral density in upper and lower extremities during 12 months after spinal cord injury measured by peripheral quantitative computed tomography. Spinal Cord 2000; 38: 26-32.
  pubmed

• 10. Lueken SA, et al. Changes in markers of bone formation and resorption in a bed rest model of weightlessness. J Bone Miner Res 1993; 8: 1433-8.

• 11. Thomsen JS, et al. Cancellous bone structure of iliac crest biopsies following 370 days of head-down bed rest. Aviat Space Environ Med 2005; 76: 915-22.
  pubmed

• 12. Lazo MG, et al. Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord 2001; 39: 208-14.
  pubmed

• 13. Vestergaard P, et al. Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord 1998; 36: 790-6.
  pubmed

• 14. Dauty M, et al. Supralesional and sublesional bone mineral density in spinal cord-injured patients. Bone 2000; 27: 305-9.
  pubmed

• 15. Jorgensen L, Jacobsen BK. Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: A 1 year prospective study. Bone 2001; 28: 655-9.
  pubmed

• 16. Smith SM, et al. Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the mir space station. J Bone Miner Res 2005; 20: 208-18.
  pubmed

• 17. Giangregorio L, Blimkie CJ. Skeletal adaptations to alterations in weight-bearing activity: A comparison of models of disuse osteoporosis. Sports Med 2002; 32: 459-76.
  pubmed

• 18. Arnaud SB, et al. Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system. Aviat Space Environ Med 1992; 63: 14-20.

• 19. Vico L, et al. Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 2000; 355: 1607-11.
  pubmed

• 20. Gerdhem P, et al. Effect of previous and present physical activity on bone mass in elderly women. Osteoporos Int 2003 14: 208-12.

• 21. Karlsson MK, et al. Exercise during growth and bone mineral density and fractures in old age. Lancet 2000; 355: 469-70.
  pubmed

• 22. Nguyen TV, et al. Bone loss, physical activity, and weight change in elderly women: The Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 1998; 13: 1458-67.
  pubmed

• 23. Oka H, et al. Decreased activities of daily living and associations with bone loss among aged residents in a rural Japanese community: The Miyama Study. J Bone Miner Metab 2006; 24: 307-13.

• 24. Hannan MT, et al. Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 2000; 15: 710-20.
  pubmed

• 25. Morel J, et al. Bone mineral density of 704 amateur sportsmen involved in different physical activities. Osteoporos Int 2001; 12: 152-7.
  pubmed

• 26. McClanahan BS, et al. Side-to-side comparisons of bone mineral density in upper and lower limbs of collegiate athletes. J Strength Cond Res 2002; 16: 586-90.
  pubmed

• 27. Bassey EJ, et al. Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise. J Bone Miner Res 1998; 13: 1805-13.

• 28. Dalsky Gp.Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 1988; 108: 824-8.
  pubmed

• 29. Wolff I, et al. The effect of exercise training programs on bone mass: A meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999; 9: 1-12.

• 30. Martyn-St James M, Carroll S. High-intensity resistance training and postmenopausal bone loss: A meta-analysis. Osteoporos Int 2006; 17: 1225-40.
  pubmed

• 31. Hagino H, et al. Effect of ovariectomy on bone response to in vivo external loading. J Bone Miner Res 1993; 8: 347-57.

• 32. Turner CH, Robling AG. Designing exercise regimens to increase bone strength. Exerc Sport Sci Rev 2003; 31: 45-50.
  pubmed

• 33. Frost HM. Vital biomechanics: Proposed general concepts for skeletal adaptations to mechanical usage. Calcif Tissue Int 1988; 42: 145-56.
  pubmed

• 34. Rubin CT, Lanyon LE. Limb mechanics as a function of speed and gait: A study of function strains in the radius and tibia of horse and dog. J Exp Biol 1982; 101: 187-211.

• 35. Milgrom C, et al. In-vivo strain measurements to evaluate the strengthening potential of exercises on the tibial bone. J Bone Joint Surg 2000; 82-B: 591-4.

• 36. Turner CH, et al. Mechanotransduction in bone: Role of strain rate. Am J Physiol 1995; 269: E438-42.
  pubmed

• 37. Mosley JR, Lanyon LE. Strain rate as a controlling influence on adaptive modeling in response to dynamic loading of the ulna in growing male rats. Bone 1998; 23: 313-8.
  pubmed

• 38. Robling AG, et al. Partitioning a daily mechanical stimulus into discrete loading bouts improves the osteogenic response to loading. J Bone Miner Res 2000; 15: 1596-602.
  pubmed

• 39. Burr DB, et al. Effects of biomechanical stress on bones in animals. Bone 2002; 30: 781-6.
  pubmed

• 40. Rubin C, et al. Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. J Bone Miner Res 2002; 17: 349-57.
  pubmed

• 41. Hirano Y, et al. Longitudinal change in periprosthetic, peripheral, and axial bone mineral density after total hip arthroplasty. Mod Rheumatol 2001; 11: 217-21.
  pubmed

• 42. Turner CH. Toward a mathematical description of bone biology: The principle of cellular accommodation. Calcif Tissue Int 1999; 65: 466-71.

P.71 掲載の参考文献

• 1. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1991; 90: 107-10.
  pubmed

• 2. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94: 646-50.
  pubmed

• 3. NIH Consensus Development Panel. JAMA 2001; 285: 785-95.
  pubmed

• 4. Kanis JA, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-41.

• 5. 折茂 肇ほか. 原発性骨粗鬆症の診断基準 (1996年改訂版). 日骨代謝誌1997; 14: 219-33.

• 6. 折茂 肇ほか. 原発性骨粗鬆症の診断基準 (2000年度改訂版). 日骨代謝誌2001; 18: 76-82.

• 7. Melton LJ 3rd, Riggs BL. Clinical spectrum. In: Riggs BL, Melton LJ 3rd, editors. Osteoporosis. New York: Raven Press; 1988. p.155-79.

• 8. 中塚喜義, 西沢良記. 続発性骨粗鬆症とは. Bone 1999; 13: 19-25.

• 9. Barnes PJ. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci 1998; 94: 557-72.
  pubmed

• 10. Cato AC, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996; 18: 371-8.
  pubmed

• 11. Walsh LJ, et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study. BMJ 1996; 313: 344-6.
  pubmed

• 12. Huizenga NA, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998; 83: 144-51.
  pubmed

• 13. Ekenstam E, et al. The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism 1988; 37: 141-4.
  pubmed

• 14. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999; 14: 1061-6.

• 15. Delany AM, et al. Cortisol down regulates osteoblast α 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem 1995; 57: 488-94.

• 16. Weinstein RS, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998; 102: 274-82.

• 17. Hofbauer LC, et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 1999; 140: 4382-9.
  pubmed

• 18. Yasuda H, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998; 95: 3597-602.
  pubmed

• 19. Hahn TJ, et al. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 1981; 52: 111-5.

• 20. Reid IR, Ibbertson HK. Evidence for decreased tubular reabsorption of calcium in glucocorticoid treated asthmatics. Horm Res 1987; 27: 200-4.
  pubmed

• 21. Guistina A, et al. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 1995; 80: 122-9.

• 22. Sugimoto T, et al. Combined effects of dexamethasone and 1,25-dihydroxy vitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Endocrinology 1989; 125: 638-41.

• 23. van Staa TP, et al. The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporos Int 2002; 13: 777-87.
  pubmed

• 24. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990; 112: 352-64.
  pubmed

• 25. Chiodini I, et al. Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 1998; 83: 1863-7.
  pubmed

• 26. van Staa TP, et al. Use of oral corticosteroids in the United Kingdom. QJM 2000; 93: 105-11.
  pubmed

• 27. van Staa TP, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000; 15: 993-1000.
  pubmed

• 28. Luengo M, et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: A comparative study. Thorax 1991; 46: 803-6.
  pubmed

• 29. Nawata H, et al. The Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis: Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005; 23: 105-9.
  pubmed

• 30. 田中郁子, 大島久二. ステロイド性骨粗鬆症の診断と治療に関する縦断研究-診断・治療指針への予備的検討. Osteo-porosis Jpn 2003; 11: 11-4.

• 31. Canalis E, Giustina A. Glucocorticoid-induced osteoporosis: Summary of a workshop.J Clin Endocrinol Metab 2001; 86: 5681-5.
  pubmed

• 32. National Osteoporosis Society, Bone and Tooth Society of Great Britain, Royal College of Physicians. Glucocorticoid-induced osteoporosis: A concise guide to prevent and treatment. London: The Royal College of Physicians of London; 2002. p.1-57.

• 33. Vestergaard P, et al. Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 2002; 146: 51-6.
  pubmed

• 34. Francucci CM, et al. Bone metabolism and mass in women with Cushing's syndrome an adrenal incidentaloma. Clin Endocrinol (Oxf) 2002; 57: 587-93.
  pubmed

• 35. Hermus AR, et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995; 80: 2859-65.
  pubmed

• 36. Manning PJ, et al. Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf) 1992; 36: 229-34.
  pubmed

• 37. Di Somma C, et al. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study. Clin Endocrinol (Oxf) 2003; 58: 302-8.
  pubmed

• 38. Leong GM, et al. The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: A report of an identical adolescent twin pair. J Clin Endocrinol Metab 1996; 81: 1905-11.

• 39. Baran DT. The skeletal system in thyrotoxicosis. In: Braverman LK, Utiger RD, editors. The Thyroid. New York: Lippincott-Raven; 1996. p.678-86.

• 40. 北濱眞司, 和田誠基. 各種疾患と骨粗鬆症 (甲状腺機能異常). 日本骨粗鬆学会編. 続発性骨粗鬆症の治療マニュアル. 東京: ライフサイエンス出版; 2000. p.40-4.

• 41. Alloain TJ, et al. The isoforms-specific expression of the tri-iodothyronine receptor in osteoblast and osteoclast. Eur J Clin Invest 1996; 26: 418-25.

• 42. Diamond T, et al. Thyrotoxic bone disease in women: A potentially reversible disorder. Ann Intern Med 1994; 120: 8-11.
  pubmed

• 43. Franklyn J, et al. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol (Oxf) 1994; 41: 425-32.

• 44. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk: A meta-analysis. Thyroid 2003; 13: 585-93.

• 45. Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: A nation-wide follow-up study in 16,249 patients. Thyroid 2002; 12: 411-9.

• 46. Vestergaard P, et al. Fracture risk in patients treated for hyperthyroidism. Thyroid 2000; 10: 341-8.
  pubmed

• 47. Christiansen P, et al. Primary hyperparathyroidism: Iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992; 13: 41-9.
  pubmed

• 48. Horiuchi T, et al. A strategy for the management of elderly women with primary hyperparathyroidism: A comparison of etidronate therapy with parathyroidectomy. Gerontology 2002; 48: 103-8.
  pubmed

• 49. Dempster DW, et al. Asymptomatic primary hyperparathyroidism: New issue and new questions: Bridging the past with the future. J Bone Miner Res 2002; 17: N57-67.

• 50. Melton LJ 3rd, et al. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 1992; 152: 2269-73.
  pubmed

• 51. Silvernberg SJ, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341: 1249-55.
  pubmed

• 52. Colvard DS, et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci U S A 1989; 86: 854-7.
  pubmed

• 53. Orwoll ES, et al. Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 1991; 49: 183-7.
  pubmed

• 54. Pederson L, et al. Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad Sci U S A 1999; 96: 505-10.
  pubmed

• 55. Sasano H, et al. Aromatase in human bone tissue. J Bone Miner Res 1997; 12: 1416-23.
  pubmed

• 56. Stepan JJ, et al. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69: 523-7.
  pubmed

• 57. Daniell HM. Osteoporosis after orchidectomy for prostate cancer. J Urol 1997; 157: 439-44.

• 58. Leifke E, et al. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 1998; 138: 51-8.
  pubmed

• 59. Levy JR, et al. Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells. Endocrinology 1986; 119: 1786-92.
  pubmed

• 60. Inaba M, et al. Influence of high glucose on 1,25-dihydroxy vitamin D3-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res 1995; 10: 1050-6.

• 61. Kawagishi T, et al. Parathyroid hormone secretion in diabetes mellitus. Contrib Nephrol 1991; 90: 217-22.
  pubmed

• 62. 野村和至ほか. 糖尿病. Bone 2004; 18: 293-8.
  Medical*Online

• 63. Brown SA, Sharpless JL. Osteoporosis: An under-appreciated complication of diabetes. Clinical Diabetes 2004; 22: 10-20.

• 64. McNair p.Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus. Dan Med Bull 1988; 35: 109-21.
  pubmed

• 65. Tuominen JT, et al. Bone mineral density in patients with type 1 and 2 diabetes. Diabetes Care 1999; 22: 1196-200.
  pubmed

• 66. Okuno Y, et al. Total and regional bone mineral content in patients with non-insulin-dependent diabetes mellitus. J Nutr Sci Vitaminol (Tokyo) 1991; 37 Suppl 1: S43-9.

• 67. Suzuki K, et al. Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients. Diabetes Res Clin Pract 2000; 48: 185-91.
  pubmed

• 68. Inaba M, et al. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dehydroxyvitamin D3 patients with type 2 diabetes. Osteoporos Int 1999; 9: 525-31.

• 69. Nicodemus KK, Folsom AR; Iowa Women's Health Study Group.Type 1 and type 2 diabetes and icident hip fractures in postmenopausal women. Diabetes Care 2001; 24: 1192-7.

• 70. Schwartz AV, et al; Study of Osteoporotic Features Research Group.Older women with diabetes have an increased risk of fracture: A prospective study. J Clin Endocrinol Metab 2001; 86: 32-8.

• 71. 折茂 肇ほか. 骨粗鬆症の治療 (薬物療法) に関するガイドライン-2002年度改訂版. Osteoporosis JPN 2002; 10: 635-709.

• 72. Bisballe S, et al. Osteopenia and osteomalacia after gastrectomy: Interrelations between biochemical markers of bone remodeling,vitamin D metabolites, and bone histomorphometry. Gut 1991; 32: 1303-7.
  pubmed

• 73. 尾形悦郎. 胃切除後. Bone 2004; 18: 299-302.
  Medical*Online

• 74. Zittel TT, et al. High prevalence of bone disorders after gastrectomy. Am J Surg 1997; 174: 431-8.
  pubmed

• 75. Nilas L, et al. Regulation of vitamin D and calcium metabolism after gastrectomy. Gut 1985; 26: 252-7.
  pubmed

• 76. Davies M, et al. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels: Implications for metabolic bone disease. J Clin Endocrinol Metab 1997; 82: 209-12.
  pubmed

• 77. Inoue K, et al. Metabolic bone disease following gastrectomy: Assessment by dual energy X-ray absorptiometry. Br J Surg 1992; 79: 321-4.
  pubmed

• 78. Adachi Y, et al. Osteoporosis after gastrectomy: Bone mineral density of lumbar spine assessed by dual-energy X-ray absorptiometry. Calcif Tissue Int 2000; 66: 119-22.
  pubmed

• 79. Heiskanen JT, et al. Bone mineral metabolism after total gastrectomy. Bone 2001; 28: 123-7.
  pubmed

• 80. Ponchon G, et al. Activation of vitamin D by the liver. J Clin Invest 1969; 48: 2032-7.

• 81. Lawson DEM, et al. Identification of 1,25-dihydroxy-cholecalciferol: A new kidneyhormone controlling calcium metabolism. Nature 1971; 230: 228-30.

• 82. 鈴木壱知ほか. 慢性肝疾患. Bone 2004; 18: 303-6.
  Medical*Online

• 83. Collier JD, et al. Guideline on the management of the osteoporosis associated with chronic liver disease. Gut 2002; 50 Suppl 1: i1-19.

• 84. Llach F. Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited. Am J Kidney Dis 1995; 25: 663-79.
  pubmed

• 85. 川村仁美, 重松 隆. 腎疾患. Bone 2004; 18: 315-9.
  Medical*Online

• 86. Zerwekh JE, et al. The effects of 12 weeks bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in 11 normal subjects. J Bone Miner Res 1998; 13: 1594-601.

• 87. LeBlanc AD, et al. Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 1990; 5: 843-50.
  pubmed

• 88. Smith SM, et al. Collagen cross-link excretion during space flight and bed rest. J Clin Endocrionl Metab 1998; 83: 3584-91.

• 89. Shigematsu T, et al. Changes in bone and calcium metabolism with space flight. Osteoporos Int 1997; 7 Suppl 3: S63-7.

• 90. Takata S, et al. Characteristics of regional bone mineral density and soft tissue composition in patients with atraumatic vertebral fractures. J Bone Miner Metab 2000; 18: 287-90.
  pubmed

• 91. Kedlaya D, et al. Immobilization hypercalcemia in incomplete paraplegia: Successful treatment with pamidronate. Arch Phys Med Rehabil 1998; 79: 222-5.
  pubmed

• 92. Fleisch HA. Bisphosphonates: Preclinical aspects and use in osteoporosis. Ann Med 1997; 29: 55-62.
  pubmed

• 93. 高田信二郎. 不動と廃用性骨萎縮. Bone 2004; 18: 333-7.

P.82 掲載の参考文献

• 1. 厚生労働省監. 平成16年度厚生労働白書. 東京: ぎょうせい; 2004.

• 2. Morita Y, et al. The incidence of cervical and trochanteric fractures of the proximal femur in 1999 in Niigata Prefecture, Japan. J Bone Miner Metab 2002; 20: 311-8.
  pubmed

• 3. 遠藤直人ほか. 運動器疾患の病態と治療. 新潟市医師会報2003; 384: 2-6.

• 4. 徳永邦彦ほか. 円背が骨粗鬆症患者の Quality of Life に及ぼす影響. Osteoporosis Japan 2001; 9: 480-4.

• 5. WHO report. Technical report 921: Prevention and management of osteoporosis. 2003.

• 6. 日本骨代謝学会骨粗鬆症診断基準検討委員会. 原発性骨粗鬆症の診断基準. 2000年度改訂版. 日本骨代謝学会雑誌 2001; 18: 76-82.
  Medical*Online

• 7. 骨粗鬆症の治療 (薬物治療) に関するガイドライン作成ワーキンググループ. 骨粗鬆症の治療 (薬物療法) に関するガイドライン. 2002年度改訂版. Osteoporosis Japan 2002; 10: 637-709.

• 8. Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis. Year 2000 revision. J Bone Miner Metab 2001; 19: 331-7.

• 9. 折茂 肇. 原発性骨粗鬆症の診断基準. 2000年度改訂版. Osteoporosis Japan 2001; 9: 9-14.

• 10. Fukunaga M, et al. Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women. J Bone Miner Metab 2004; 22: 104-10.
  pubmed

• 11. Genant HK, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8: 1137-48

• 12. Nawata H, et al. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research. J Bone Miner Metab 2005; 23: 105-9.

• 13. Arai K, et al. Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: A cross-sectional and longitudinal study. J Bone Miner Metab 2006; 24: 118-24.
  pubmed

• 14. 日本骨粗鬆症学会 骨粗鬆症診療における骨代謝マーカーの適正使用に関する指針検討委員会. 骨粗鬆症診療における骨代謝マーカーの適正使用ガイドライン. 2004年度版. Osteoporosis Japan 2004; 12: 191-238.

• 15. Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis, Japan Osteoporosis Society. Guidelines on the use of biochemical markers of bone turnover in osteoporosis. J Bone Miner Metab 2001; 19: 338-44.

• 16. 遠藤直人, 高橋栄明. 組織学的骨形態計測法. 辻陽雄, 高橋栄明編. 整形外科診断学. 改訂第3版. 東京: 金原出 版; 1999. p.745-57.

• 17. 岩谷 力ほか. OPACによる骨粗鬆症患者のQOL評価. 日本骨代謝学会雑誌2000; 17: 136-40.

• 18. 高橋栄明ほか. 骨粗鬆症患者QOL評価質問表. 日本骨代謝学会雑誌2001; 18: 83-101.

• 19. 岡野登志夫ほか. 高齢者を中心とした日本人女性のビタミンD栄養状態と骨代謝関連指標について. Osteoporosis Japan 2004; 12: 77-9.

• 20. Sakuma M, et al. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006; 17: 1608-14.
  pubmed

• 21. 遠藤直人. 骨粗鬆症の診断, 治療ガイドライン. 診療ガイドライン骨粗鬆症. http://www.ebm.jp/disease/bone/03kotsusosho/guide.html

• 22. 骨粗鬆症の予防と治療ガイドライン作成委員会 (代表折茂 肇). 骨粗鬆症の予防と治療のガイドライン. 2006年版. 東京: ライフサイエンス出版; 2006.

P.96 掲載の参考文献

• 1. Orimo H, et al. Diagnostic criteria for primary osteoporosis: Year 2000 revision. J Bone Miner Metab 2001; 19: 331-7.

• 2. Siris ES, et al. Bone mineral density threshold for pharmacological intervention to prevent farctures. Arch Intern Med 2004; 164: 1108-12.

• 3. 伊木雅之編. 地域保健におけるエビデンスに基づく骨折・骨粗鬆症予防ガイドライン. 東京: 日本公衆衛生協会, ニッポンパブリシティ; 2004.

• 4. Liberman UA, et al. Effects of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis. N Engl J Med 1995; 333; 1437-43.

• 5. Black DM, et al for the Fracture Intervention Trial Research Group.Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fracture. Lancet 1996; 348: 1535-41.

• 6. Cummings SR, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the fracture intervention trial. JAMA 1998; 280: 2077-82.
  pubmed

• 7. Harris ST, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 1999; 282: 1344-52.
  pubmed

• 8. Ettinger B, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. JAMA 1999; 282: 637-45.
  pubmed

• 9. Reginster JY, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000; 11: 83-91.

• 10. Chesnut CH 3rd, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fracture study. PROOF Study Group.Am J Med 2000; 109: 267-76.

• 11. McClung MR, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001; 344: 333-40.
  pubmed

• 12. Rossouw JE, et al, Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.

• 13. 藤田拓男ほか. 退行期骨粗鬆症に対するアルファカルシドールを対照としたエチドロン酸二ナトリウム (EHDP) の二重盲検比較試験. Clin Eval 1993; 21: 261-302.

• 14. Orimo H, et al. Effects of 1-α-hydroxy vitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994; 54: 370-6.

• 15. Shiraki M, et al. Effects of 2 years' treatment of osteoporosis with 1α-hydroxy vitamin D3 on bone mineral density and incidence of fracture: A placebo-controlled, double-blind prospective study. Endocr J 1996; 43: 211-20.

• 16. Kushida K, et al on behalf of the Alendronate/Alfacalcidol Fracture Intervention Study Group.The efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: A randomized, double-blind, active-controlled, double-dummy trial. Curr Ther Res Clin Exp 2002; 63: 606-20.

• 17. Ishida Y, Kawai S. Comparative efficacy of hormone replacement therapy, etidronate calcitonin, alfacalcidol, vitamin K2 in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med 2004; 117: 549-55.

• 18. Shiraki M, et al. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis. J Bone Miner Metab 2004; 22: 352-9.

• 19. Kushida K, et al. Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: A 3-year follow up study. J Bone Miner Metab 2004; 22: 462-8.
  pubmed

• 20. 折茂 肇ほか. 骨粗鬆症に対するEa-0167 (menatetrenone) の臨床評価-アルファカルシドールを対照とした臨床第III相多施設二重盲検比較試験. Clin Eval 1992; 20: 45-100.

• 21. Yonemura K, et al. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int 2000; 66: 123-8.
  pubmed

• 22. Shiraki M, et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000; 15: 515-21.

• 23. Iwamoto J, et al. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: A comparison with the effect of etidronate. J Orthop Sci 2001; 6: 487-92.

• 24. Sato Y, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002; 31: 114-8.

• 25. Yonemura K, et al. Protective effect of vitamin K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine. Am J Kidney Dis 2004; 43: 53-60.
  pubmed

• 26. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-95.
  pubmed

• 27. Chapurlat RD, et al. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: The EPIDOS study. Bone 2000; 27: 283-6.
  pubmed

• 28. Garnero P, et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 2000; 15: 1526-36.
  pubmed

• 29. Garnero P, et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996; 11: 337-49.

• 30. Gerdhem P, et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004; 19: 386-93.

• 31. Shiraki M, et al. The sample size required for intervention studies on fracture prevention can be reduced by using a bone resorption marker in the inclusion criteria: Prospective study of a subset of the Nagano cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group.J Bone Miner Metab 2006; 24: 219-25 .

• 32. Chen JT, et al. 1-α hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 1997; 20: 557-62.

• 33. Wimalawansa SJ. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med 1998; 104: 219-26.

• 34. Shiraki M, et al. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int 1999; 10: 183-92.
  pubmed

• 35. Shiraki M, et al. A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the risedronate late phase II research group). Osteoporos Int 2003; 14: 225-34.

• 36. Seibel MJ, et al. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J Bone Miner Res 2004; 19: 323-9.

• 37. Bauer DC, et al. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: The fracture intervention trial. J Bone Miner Res 2006; 21: 292-9.

• 38. 白木正孝. 治療薬の骨折予防効果に関する多剤比較試験 (中間解析). 日老医誌2006; 43: 45-7.

• 39. Reginster JY, et al. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. Bone 2004; 34: 344-51.
  pubmed

• 40. Gonelli S, et al. The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis. J Bone Miner Res 1997; 12: 624-31.

• 41. Civitelli R, et al. Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. J Clin Invest 1999; 82: 1268-74.

• 42. Hansen MA, et al. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. Br Med J 1991; 303: 961-4.

• 43. 藤田拓男ほか. 骨粗鬆症に対するエルカトニンの効果-プラセボを対照薬とした多施設二重盲検比較試験. 医のあゆみ 1990; 152; 261-82.
  Medical*Online

• 44. Nevitt MC, et al. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing fractures. Arch Intern Med 2000; 160: 77-85.
  pubmed

• 45. Silverman SL, et al. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis. Arthritis Rheum 2001; 44; 2611-9.
  pubmed

• 46. Lips P, et al. Determinations of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 1987; 46: 1005-10.
  pubmed

• 47. Ooms ME, et al. Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 1995; 10: 1177-84.
  pubmed

• 48. Lips p.Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
  pubmed

• 49. Chapuy MC, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
  pubmed

• 50. Lips P, et al. Vitamin D supplementation and fracture incidence in elderly persons: A randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124: 400-6.

• 51. Thomas MK, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-83.
  pubmed

• 52. Orimo H, et al. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1α-hydroxy vitamin D3. Bone Miner 1987; 3: 47-52.

• 53. Hart JP, et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab 1985; 60: 1268-9.

• 54. Feskanich D, et al. Vitamin K intake and hip fractures in women: A prospective study. Am J Clin Nutr 1999; 69: 74-9.
  pubmed

• 55. Sato Y, et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: A randomized controlled trial. JAMA 2005; 293: 1082-8.
  pubmed

• 56. van Meurs JB, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350: 2033-41.
  pubmed

• 57. McLean RR, et al. Homocysteine as apredictive factor for hip fracture in older persons. N Engl J Med 2004; 350: 2042-9.

• 58. Kaneki M, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk. Nitrition 2001; 17: 315-21.

• 59. Watts NB, et al. Risedronate prevents new vertebral fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 2003; 88: 538-41.

• 60. Siris E, et al. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: Results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Osteoporos Int 2002; 13: 907-13.
  pubmed

• 61. Delmas PD, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE trial. Bone 2003; 33; 522-32.
  pubmed

P.104 掲載の参考文献

• 1. 広田孝子ほか. 骨粗鬆症の治療法. 栄養法. 骨粗鬆症一次, 二次予防を志向した栄養療法. 日本臨牀2004; 62 増刊号 2: 515-20.

• 2. Hirota T, et al. Effect of diet and lifestyle on bone mass in Asian young women. Am J Clin Nutr 1992; 55: 1168-73.

• 3. Welten DC, et al. A meta-analysis of the effects of calcium intake on bone mass in young and middle aged females and males. J Nutr 1995; 125: 2802-13.

• 4. Cummings SR, et al. Calcium for prevention of osteoporotic fracture in postmenopausal women. J Bone Miner Res 1997; 12: 1321-9.

• 5. Xu L, et al. Does dietary calcium have a protective effect on bone fracture in women? Br J Nutr 2004; 91: 625-34.

• 6. 骨粗鬆症の治療 (薬物療法) に関するガイドライン-2002年度改訂版. Osteoporosis Japan 2002; 10: 637-709.

• 7. Bischoff-Ferrari HA, et al. Effect of vitamin D on falls-a meta-analysis. JAMA 2004; 291: 1999-2006.

• 8. Lloyd T, et al. Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997; 65: 1826-30.
  pubmed

• 9. Holbrook TL, et al. A prospective study of alcohol consumption and bone mineral density. BMJ 1993; 306: 1506-9.
  pubmed

• 10. Kiel DP, et al. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med 1992; 116: 716-21.
  pubmed

• 11. Krall EA, et al. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res 1999; 14: 215-20.
  pubmed

• 12. Morris FL, et al. Prospective ten-month exercise intervention in premenarcheal girls: Positive effects on bone and mean mass. J Bone Miner Res 1997; 12: 1453-62.

• 13. Bradney M, et al. Moderate exercise during growth in prepubertal boys; Changes in bone mass, size, volumetric density, and bone strength: A controlled prospective study. J Bone Miner Res 1998; 13: 1814-21.
  pubmed

• 14. Report of a WHO Scientific Group.Prevention and management of osteoporosis. WHO Technical Report Series 921. Geneva: World Health Organization; 2003.
  pubmed

• 15. Silman AJ, et al. Influence of physical activity on vertebral deformity in men and women: Results from the European Vertebral Osteoporosis Study. J Bone Miner Res 1997; 12: 813-9.
  pubmed

• 16. Gregg EW, et al. Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group.Ann Intern Med 1998; 129: 81-8.

• 17. Berard A, et al. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int 1997; 7: 331-7.
  pubmed

• 18. Wolff I, et al. The effect of exercise training programs on bone mass: A meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999; 9: 1-12.

• 19. Kelley GA, et al. Resistance training and bone mineral density in women: A meta-analysis of controlled trials. Am J Phys Med Rehabil 2001; 80: 65-77.
  pubmed

• 20. Bonaiuti D, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2002; 3: CD000333.
  pubmed

• 21. Yamazaki S, et al. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis. J Bone Miner Metab 2004; 22: 500-8.

• 22. Province MA, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273: 1341-7.
  pubmed

• 23. Robertson MC, et al. Preventing injuries in older people by preventing falls: A meta-analysis of individual-level data. J Am Geriatr Soc 2002; 50: 905-11.

• 24. O'Neill TW, et al. Risk factors, falls, and fracture of the distal forearm in Manchester, UK. J Epidemiol Community Health 1996; 50: 288-92.

• 25. 黒柳律雄ほか. 骨粗鬆症の治療法. 運動療法. 骨粗鬆症患者に対する運動処方の実際. 日本臨牀2004; 62 増刊号2: 505-9.

3章 脆弱性骨折

P.116 掲載の参考文献

• 1. 清野佳紀ほか. 小児の骨発育と骨障害 (骨折) に関する研究-分担研究報告. 厚生省心身障害研究 生活環境が子どもの健康や心身の発育におよぼす影響に関する研究. 平成7年度研究報告. 1995. p.59-64.

• 2. Mazess RB. On aging bone loss. Clin Orthop Relat Res 1982; 165: 239-52.
  pubmed

• 3. National Institutes of Health. Osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 2003; 17: 1-36.

• 4. Cummings SR, Black D. Bone mass measurements and risk fracture in Caucasian women: A review of findings from prospective studies. Am J Med 1995; 98: 24S-8S.
  pubmed

• 5. Ross PD, et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol 1995; 24: 1171-7.
  pubmed

• 6. Silva MJ, et al. Direct and computed tomography thickness measurements of the human, lumbar vertebral shell and endplate. Bone 1994; 15: 409-14.
  pubmed

• 7. Keller TS, et al. Regional variations in the compressive properties of lumbar vertebral trabeculae: Effects of disc degeneration. Spine 1989; 14: 1012-9.
  pubmed

• 8. Grant JP, et al. The effects of bone density and disc degeneration on the structural property distributions in the lower lumbar vertebral endplates. J Orhtop Res 2002; 20: 1115-20.
  pubmed

• 9. Hansson T, et al. The bone mineral content and ultimate compressive strength of lumbar vertebrae. Spine 1980; 5: 46-55.
  pubmed

• 10. McBroom RJ, et al. Prediction of vertebral body compressive fracture using quantitative computed tomography. J Bone Joint Surg Am 1985; 67: 1206-14.
  pubmed

• 11. Vernon-Roberts B, Pirie CJ. Healing trabecular microfractures in the bodies of lumbar vertebrae. Ann Rheum Dis 1973; 32: 406-12.
  pubmed

• 12. Hasegawa K, et al. Failure characteristics of osteoporotic vertebral bodies monitored by acoustic emission. Spine 1993; 18: 2314-20.
  pubmed

• 13. Tertti M, et al. Disc degeneration in magnetic resonance imaging: A comparative biochemical, histological, and radiological study in cadaver spines. Spine 1991; 16: 629-34.
  pubmed

• 14. Hasegawa K, et al. Effect of disc lesion on microdamage accumulation in lumbar vertebrae under cyclic compression loading. Clin Orthop Relat Res 1995; 311: 190-8.
  pubmed

• 15. Hansson TH, et al. Mechanical behavior of the human lumbar spine. II. Fatigue strength during dynamic compression loading. J Orthop Res 1987; 5: 479-87.
  pubmed

• 16. Hasegawa K. Osteoporotic pseudoarthrosis: Another instability of the spine. In: Takahashi HE, editor. Mechanical Loading of Bones and Joints. Tokyo: Springer-Verlag; 1999. p.69-76.

• 17. Nachemson A. Lumbar intradiscal pressure: Experimental studies on post-mortem material. Acta Orthop Scand 1960; Suppl 43: 1-104.
  pubmed

• 18. 長谷川和宏ほか. 脊椎圧迫骨折における手術療法の適応. 整災外1999; 42: 1107-15.

• 19. Kado DM, et al. Vertebral fractures and mortality in older women: A prospective study. Study for Osteoporotic Fractures Research Group.Arch Intern Med 1999; 159: 1215-20.

• 20. Leech JA, et al. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 1990; 141: 68-71.
  pubmed

• 21. Ross PD, et al. Pain and disability associated with new vertebral fractures and other spinal conditions. J Clin Epidemiol 1994; 47: 234-9.

• 22. Hasegawa K, et al. Vertebral pseudoarthrosis in the osteoporotic spine. Spine 1998; 23: 2201-6.
  pubmed

• 23. Cho T, et al. MRI findings on healing process of vertebral fracture in osteoporosis. J Orthop Sci 1996; 1: 16-33.

• 24. 徳橋泰明, 松崎浩巳. 転移性脊椎腫瘍. 特集 脊椎・脊髄画像診断マニュアル. MB Orthop 2002; 15: 138-46.

• 25. 石河紀之ほか. 骨粗鬆症の脊椎骨折に対する体幹ギプス固定. Osteoporosis Japan. 1999; 7: 27-31.

• 26. Berard A, et al. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int 1997; 7: 331-7.
  pubmed

• 27. Malmros B, et al. Positive effects of physiotherapy on chronic pain and performance in osteoporosis. Osteoporos Int 1998; 8: 215-21.
  pubmed

• 28. Kaneda K, et al. The treatment of osteoporotic-posttraumatic vertebral collapse using the Kaneda device and a bioactive ceramic vertebral prosthesis. Spine 1992; 17: S295-303.

• 29. Shikata J, et al. Surgical treatment for paraplegia resulting from vertebral fractures in senile osteoporosis. Spine 1990; 15: 485-9.
  pubmed

• 30. Garfin SR, et al. New technologies in spine: Kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures. Spine 2001; 26: 1511-5.
  pubmed

P.126 掲載の参考文献

• 1. Orimo H, et al. Trends in the incidence of hip fracture in Japan, 1987-1997: The third nationwide survey. J Bone Miner Metab 2000; 18: 126-31.
  pubmed

• 2. Committee for Osteoporosis Treatment of The Japanese Orthopaedic Association. Nationwide survey of hip fractures in Japan. J Orthop Sci 2004; 9: 1-5.
  pubmed

• 3. Hagino H, et al. Increasing incidence of hip fracture in Tottori Prefecture, Japan: Trend from 1986 to 2001. Osteoporos Int 2005; 16: 1963-8.
  pubmed

• 4. Hagino H, et al. Changing incidence of hip, distal radius, and proximal humerus fractures in Tottori Prefecture, Japan. Bone 1999; 24: 265-70.
  pubmed

• 5. Faulkner KG, et al. Simple measurement of femoral geometry predicts hip fracture: The study of osteoporotic fractures. J Bone Miner Res 1993; 8: 1211-7.

• 6. Aoyagi K, et al. Falls among community-dwelling elderly in Japan. J Bone Miner Res. 1998; 13: 1468-74.
  pubmed

• 7. Marshall D, et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-9.
  pubmed

• 8. Klotzbuecher CM, et al. Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-39.
  pubmed

• 9. Vergnaud P, et al. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS Study. J Clin Endocrinol Metab 1997; 82: 719-24.
  pubmed

• 10. Garnero P, et al. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 1996; 11: 1531-8.
  pubmed

• 11. Lotz JC, Hayes WC. The use of quantitative computed tomography to estimate risk of fracture of the hip from falls. J Bone Joint Surg Am 1990; 72: 689-700.

• 12. Nevitt MC. Fall in the elderly: Risk factors and prevention. In: Masdeu JC, et al, editors. Gait Disorders of Aging. Philadelphia/New York: Lippincott-Raven; 1997.

• 13. Masud T, Morris RO. Epidemiology of falls. Age Ageing 2001; 30 Suppl 4: 3-7.

• 14. 安村誠司. 高齢者の転倒・骨折の頻度. 日医雑誌1999; 122: 1945-9.

• 15. Fairclough J, et al. Bone scanning for suspected hip fractures: A prospective study in elderly patients. J Bone Joint Surg Br 1987; 69: 251-3.
  pubmed

• 16. Rizzo PF, et al. Diagnosis of occult fractures about the hip: Magnetic resonance imaging compared with bone-scanning. J Bone Joint Surg Am 1993; 75: 395-401.
  pubmed

• 17. Garden RS. Low-angle fixation in fractures of the femoral neck. J Bone Joint Surg 1961; 43B: 647-63.

• 18. Parker MJ. Garden grading of intracapsular fractures: Meaningful or misleading ? Injury 1993; 24: 241-2.
  pubmed

• 19. Evans EM. The treatment of trochanteric fractures of the femur. J Bone Joint Surg 1949; 31B: 190-203.

• 20. Raaymakers EL, Marti RK. Non-operative treatment of impacted femoral neck fractures: A prospective study of 170 cases. J Bone Joint Surg Br 1991; 73: 950-4.

• 21. Cserhati P, et al. Non-operative or operative treatment for undisplaced femoral neck fractures: A comparative study of 122 non-operative and 125 operatively treated cases. Injury 1996; 27: 583-8.

• 22. Levi N. Dynamic hip screw versus 3 parallel screws in the treatment of garden 1+2 and garden 3+4 cervical hip fractures. Panminerva Med 1999; 41: 233-7.
  pubmed

• 23. 越智龍弥ほか. 大腿骨頸部内側骨折に対するCHS固定法の治療成績. 整外と災外2000; 49: 737-40.

• 24. Chiu FY, et al. Percutaneous pinning in undisplaced subcapital femoral neck fractures. Injury 1996; 27: 53-5.
  pubmed

• 25. Koval KJ, et al. Weight bearing after hip fracture: A prospective series of 596 geriatric hip fracture patients. J Orthop Trauma 1996; 10: 526-30.
  pubmed

• 26. Lu-Yao GL, et al. Outcomes after displaced fractures of the femoral neck: A meta-analysis of one hundred and six published reports. J Bone Joint Surg Am 1994; 76: 15-25.
  pubmed

• 27. Davison JN, et al. Treatment for displaced intracapsular fracture of the proximal femur: A prospective, randomised trial in patients aged 65 to 79 years. J Bone Joint Surg Br 2001; 83: 206-12.
  pubmed

• 28. Parker MJ. Internal fixation or arthroplasty for displaced subcapital fractures in the elderly? Injury 1992; 23: 521-4.

• 29. Parker MJ, Stockton G. Internal fixation implants for intracapsular proximal femoral fractures in adults. Cochrane Database Syst Rev 2001; (4) : CD001467.
  pubmed

• 30. Calder SJ, et al. Unipolar or bipolar prosthesis for displaced intracapsular hip fracture in octogenarians: A randomised prospective study. J Bone Joint Surg Br 1996; 78: 391-4.

• 31. Lo WH, et al. Bateman bipolar hemiarthroplasty for displaced intracapsular femoral neck fractures: Uncemented versus cemented. Clin Orthop Relat Res 1994; (302) : 75-82.
  pubmed

• 32. Parker MJ, Rajan D. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev 2001; (3) : CD001706.
  pubmed

• 33. Madsen JE, et al. Dynamic hip screw with trochanteric stabilizing plate in the treatment of unstable proximal femoral fractures: A comparative study with the Gamma nail and compression hip screw. J Orthop Trauma 1998; 12: 241-8.
  pubmed

• 34. Broos PL, et al. Pertrochanteric fractures in the elderly: Is the Belgian VDP prosthesis the best treatment for unstable fractures with severe comminution ? Acta Chir Belg 1991; 91: 242-9.
  pubmed

• 35. Hardy DC, et al. Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures: A prospective, randomized study of one hundred patients. J Bone Joint Surg Am 1998; 80: 618-30.
  pubmed

• 36. 武山憲行ほか. 手術療法を受けた65歳以上の大腿骨頸部骨折患者の予後. Hip Joint 2001; 27: 116-20.

• 37. Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23: 570-8.
  pubmed

• 38. McClung MR, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.N Engl J Med 2001; 344: 333-40.

• 39. Gillespie LD, et al. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2001; (3) : CD000340.
  pubmed

• 40. Province MA, et al. The effects of exercise on falls in elderly patients: A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273: 1341-7.
  pubmed

• 41. Gardner MM, et al. Exercise in preventing falls and fall related injuries in older people: A review of randomised controlled trials. Br J Sports Med 2000; 34: 7-17.
  pubmed

• 42. Parker MJ, et al. Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev 2001; (3) : CD001255.

P.140 掲載の参考文献

• 1. Sarmiento A, et al. Colles' fractures. J Bone Joint Surg Am 1975; 57: 311-7.
  pubmed

• 2. Axelrod T, et al. Limited open reduction of the lunate facet in comminuted intraarticular fractures of distal radius. J Hand Surg [Am]1988; 13: 372-7.
  pubmed

• 3. 堀内行雄. 橈骨遠位端骨折診断・治療マニュアル. 橈骨遠位端骨折の分類と治療方針. MB Orthop 2000; 13 (6) : 1-12.

• 4. Melone CP Jr. Distal radius fractures: Patterns of articular fragmentation. Orthop Clin North Am 1993; 24: 239-53.
  pubmed

• 5. Trumble TE, et al. Intra-articular fractures of the distal aspect of the radius. J Bone Joint Surg Am 1988; 80: 582-600.

• 6. 斎藤英彦. 橈骨遠位端骨折. 粉砕骨折の分類と治療. MB Orthop 1989; 13 (5) : 71-80.

• 7. 林 未統ほか. 橈骨遠位端骨折に続発した手根管症候群の臨床像. 日手会誌2003; 20: 390-4.

• 8. 近藤 真ほか. 橈骨遠位端骨折後の長母指伸筋腱断裂例の検討. 日手会誌1995; 12: 256-9.

• 9. Hirasawa Y, et al. Clinical and microangiographic studies on rupture of the E. p.L. tendon after distal radial fractures. J Hand Surg[Br]1990; 15: 51-7.

• 10. 佐々木孝. 橈骨遠位端骨折の保存的治療のこつと限界. 橈骨遠位端骨折の保存的治療法とその限界-特に不安定型骨折に対する保存的治療の限界症例について. 臨整外2002; 37: 1029-39.

• 11. Knirk JL, Jupiter JB. Intra-articular fractures of the distal end of the radius in young adults. J Bone Joint Surg Am 1986; 68: 647-59.
  pubmed

• 12. 西尾泰彦ほか. 橈骨遠位端骨折に対するピンニング-術後3年以上経過例の臨床成績. 日手会誌1999; 16: 6-9.

• 13. 平山拓也ほか. 橈骨遠位端骨折に対する intrafocal pinning 法の治療成績. 日手会誌1998; 14: 1005-9.

• 14. Rayhack JM, et al. Transulnar percutaneous pinning of displaced distal radius fractures: A preliminary report. J Orthop Trauma 1989; 3: 107-14.
  pubmed

• 15. 末永直樹ほか. 橈骨遠位端骨折に対するmodified transulnar percutaneous pinning. 別冊整形外科1997; 31: 43-6.

• 16. Kiyoshige Y. Condylar stabilizing technique for intraarticular fracture of distal radius. Tech Hand Up Extrem Surg 2005; 9: 17-20.
  pubmed

• 17. Ring D, et al. Prospective multicenter trial of a plate for dorsal fixation of distal radius fractures. J Hand Surg[Am]1997; 22: 777-84.
  pubmed

• 18. Kaempffe FA, et al. Severe fractures of the distal radius: Effect of amount and duration of external fixator distraction on outcome. J Hand Surg[Am]1993; 18: 33-41.
  pubmed

• 19. 石川淳一, 三浪明男. 高齢者における橈骨遠位端骨折の治療成績-Intrafocal pinning 単独群と創外固定併用群の比較. 日手会誌2002; 18: 556-8.

• 20. Gradl G, et al. Fractures of the distal radius treated with a nonbridging external fixation technique using multiplanar k-wires. J Hand Surg[Am]2005; 30: 960-8.
  pubmed

• 21. Cooney WP, Berger RA. Treatment of complex fractures of the distal radius: Combined use of internal and external fixation and arthroscopic reduction. Hand Clin 1993; 9: 603-12.
  pubmed

• 22. 山本久司, 土井一輝. 橈骨遠位端関節内骨折に対する鏡視下整復術. MB Orthop 2000; 13 (6) : 28-34.

• 23. Fernandez DL. Correction of post-traumatic wrist deformity in adults by osteotomy, bone-grafting, and internal fixation. J Bone Joint Surg Am 1982; 64: 1164-78.
  pubmed

4章 変形性膝関節症

P.146 掲載の参考文献

• 1. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis 1957; 16: 494-501.
  pubmed

• 2. Kellgren JH, Lawrence JS. Atlas of Standard Radiographs. The Epidemiology of Chronic Rheumatism vol 2. Oxford: Blackwell; 1963. p.10-1.

• 3. 川村秀哉ほか. 変形性膝関節症の疫学-患者数推定と患者調査結果の検討. 整外と災外1995; 44: 12-5.

• 4. Cooper C, et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000; 43: 995-1000.
  pubmed

• 5. 大森 豪ほか. 変形性膝関節症に対する21年間の疫学的縦断調査-松代検診2000の経験. 膝2002; 26: 243-6.

• 6. Hart DJ, et al. Incidence and risk factors for radiographic osteoarthritis in middle-age women. Arthritis Rheum 1999; 42 17-24.
  pubmed

• 7. Holmberg S, et al. Knee osteoarthritis and body mass index: A population based case-control study. Scand J Rheumatol 2005; 34: 59-64.
  pubmed

• 8. Fairbank TJ. Knee joint changes after menisectomy. J Bone Joint Surg 1948; 30B: 664-70.

• 9. Roos H, et al. Knee osteoarthritis after menisectomy. Arthritis Rheum 1998; 41: 687-93.

• 10. Kruger-Franke M, et al. Late results after arthroscopic partial medial menisectomy. Knee Surg Sports Traumatol Arthrosc 1999; 7: 81-4.

• 11. Buss DD, et al. Nonoperative treatment of acute anterior cruciate ligament injuries in a selected group of patients. Am J Sports Med 1995; 23: 160-5.

• 12. Shirakura K, et al. The natural history of untreated anterior cruciate tears in recreational athletes. Clin Orthop Relat Res 1995; 317: 227-36.
  pubmed

• 13. Hamerman D. The biology of osteoarthritis. N Engl J Med 1989; 320: 1322-30.
  pubmed

• 14. Cheng Y, et al. Physical activity and self-reported, physician-diagnosed osteoarthritis: Is physical activity a risk factor ? J Clin Epidemiol 2000; 53: 315-22.
  pubmed

• 15. Lane NE, et al. The risk of osteoarthritis with running and aging: 5-year longitudinal study. J Rheumatol 1993; 20: 461-8.
  pubmed

• 16. Sharma L, et al. The role of knee alignment in disease progression and functional decline in knee osteoarthritis JAMA 2001; 286: 188-95.
  pubmed

• 17. Zhang Y, et al. Comparison of the prevalence of the knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum 2001; 44: 2065-71.

• 18. Sowers M, et al. Radiographically defined osteoarthritis of the hand and knee in young and middle-aged African American and Caucasian women. Osteoarthritis Cartilage 2000; 8: 69-77.

• 19. 須藤啓広ほか. 変形性膝関節症の疫学的調査. 整形外科1999; 50: 1033-8.

• 20. Showers M, et al. The association of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum 1999; 42: 483-9.

• 21. Zhang Y, et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: The Framingham Study. J Rheumatol 2000; 27: 1032-7.
  pubmed

• 22. Terauchi M, et al. The influence of osteoporosis on varus osteoarthritis of the knee. J Bone Joint Surg Br 1998; 80: 432-6.
  pubmed

• 23. Yamamoto T, Bullough PG. Spontaneous osteonecrosis of the knee: The result of subchondral insufficiency fracture. J Bone Joint Surg Am 2000; 82: 858-66.
  pubmed

• 24. Wang TY, et al. Systemic necrotizing vasculitis causing bone necrosis. Am J Med 1988; 84: 1085-6.
  pubmed

• 25. Snelgrove TA, et al. Association of COL1A2, COL2A1 and COL9A1 and primary osteoarthritis in a founder population. Clin Genet 2005; 67: 359-60.

• 26. Stoop R, et al. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteroarthritis Cartilage 2001; 9: 308-15.

• 27. Pelletier JP, et al. Osteoarthritis, an inflammatory disease. Arthritis Rheum 2001; 44: 1237-47.
  pubmed

• 28. Aigner T, Kim A. Apoptosis and cellular vitality. Arthritis Rheum 2002; 46: 1986-96.

• 29. Tortorella MD, et al. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2002; 9: 539-52.

• 30. Peter G, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritis cartilage. J Clin Invest 1996; 97: 761-8.

P.156 掲載の参考文献

• 1. 腰野富久. 変形性膝関節症の病因, 分類と臨床所見. リウマチ1985; 25: 191.

• 2. 越智隆弘, 木村友厚. 変形性膝関節症の臨床症状と鑑別診断. リウマチ科1989; 1: 571-7.

• 3. Rosenberg TD, et al. The forty-five-degree posteroanterior flexion weight-bearing radiograph of the knee. J Bone Joint Surg Am 1988; 70: 1479-83.
  pubmed

• 4. Bergman AG, et al. Osteoarthritis of the knee: Correlation of subchondral MR signal abnormalities with histopathologic and radiographic features. Skeletal Radiol 1994; 23: 445-8.
  pubmed

• 5. Toda Y, et al. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998; 25: 2181-6.
  pubmed

• 6. Felson DT, et al. Obesity and knee osteoarthritis. Ann Int Med 1988; 109: 18-24.
  pubmed

• 7. Clarke GR, et al. Evaluation of physiotherapy in the treatment of osteoarthritis of the knee. Rheumatol Rehabil 1974; 13: 190-7.
  pubmed

• 8. Yasuda K, Sasaki T. The mechanics of treatment of the osteoarthritic knee with a wedged insole. Clin Orthop Relat Res 1987; 215: 162-72.
  pubmed

• 9. 真島任史, 安田和則. 内側型変形性膝関節症に対する保存療法としての足底板, 継手付き装具. MB Orthop 2003; 16: 23-8.

• 10. Friedman MJ, et al. Preliminary results with abrasion arthroplasty in the osteoarthritic knee. Clin Orthop Relat Res 1984; 182: 200-5.
  pubmed

• 11. Rodorigo JJ, et al. Improvement of full thickness chondral defect healing in the human knee after debridement and microfracture using continuous passive motion. Am J Knee Surg 1994; 7: 109-16.

• 12. 守屋秀繁ほか. 変形性膝関節症に対する鏡視下手術. 臨整外2000; 35: 135-9.

• 13. Coventry MB. Upper tibial osteotomy for osteoarthritis. J Bone Joint Surg Am 1985; 67: 1136-40.
  pubmed

• 14. Coventry MB. Osteotomy of the upper portion of the tibia for degenerative arthritis of the knee: A preliminary report. J Bone Joint Surg Am 1965; 47: 984-90.
  pubmed

• 15. Blaimont p.Curviplane osteotomy in the treatment of gonarthrosis. Acta Orthop Belg 1982; 48: 97-109.
  pubmed

• 16. 高橋敏明. 高位脛骨骨切り術. MB Orthop 2003; 16: 50-4.

• 17. 原田義昭ほか. 変形性膝関節症の自然経過. 関節外科1983; 3: 335-9.

5章 変形性脊椎症

P.160 掲載の参考文献

• 1. Feng H, et al. Extracellular matrix in disc degeneration. J Bone Joint Surg Am 2006; 88 Suppl 2: 25-9.

• 2. Roberts S, et al. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 2006; 88 Suppl 2: 10-4.

• 3. Pech P, Haughton VM. Lumbar intervertebral disc: Correlative MR and anatomic study. Radiology 1985; 156: 699-701.
  pubmed

• 4. Tertti M, et al. Disc degeneration in magnetic resonance imaging: A comparative biochemical histologic and radiologic study in cadaver spines. Spine 1991; 16: 629-34.
  pubmed

• 5. Wilder DG, et al. The biomechanics of lumbar disc herniation and the effect of overload and instability. J Spinal Disord 1988; 1: 16-32.
  pubmed

• 6. Garfin SR, et al. Spinal stenosis. In: Herkowitz HN, et al, editors. The Spine. Philadelphia: WB Saunders; 1999. p.779-96.

• 7. Naylor A. Intervertebral disc prolapse and degeneration: The biomechanical and biophysical approach. Spine 1976; 1: 108-14.

• 8. Frymoyer JW, et al. Spine radiographs in patients with low back pain. J Bone Joint Surg Am 1984; 66: 1048-55.
  pubmed

• 9. Lawrence JS. Disc degeneration: Its frequency and relationship to symptoms. Ann Rheum Dis 1969; 28: 121-38.
  pubmed

• 10. Yu SW, et al. Comparison of MR and discography in detecting radial tear of the annulus: A post-mortem study. Am J Neuroradiol 1989; 10: 1077-81.

• 11. Friedenberg ZB, Miller WT. Degenerative disc disease of the cervical spine: A comparative study of asymptomatic and symptomatic patients. J Bone Joint Surg Am 1963; 45: 1171-8.

• 12. Weinstein JN. Neck and back pain. In: Physical Medicine and Rehabilitation State of Art Review. Philadelphia: Hanley & Belfus; 1990. p.201-14.

• 13. Brisby H. Pathology and possible mechanisms of nervous system response to disc degeneration. J Bone Joint Surg Am 2006; 88 Suppl 2: 68-71.

• 14. Gore DR, et al. Neck pain: A long term follow-up of 205 patients. Spine 1987; 12: 1-5.
  pubmed

• 15. Waddell G. An approach to backache. Br J Hosp Med 1982; 28: 187.
  pubmed

• 16. Jackson CP, Brown MD. Is there a role for exercise in the treatment of patients with low back pain ? Clin Orthop Relat Res 1983; 179: 39-45.

• 17. Kelsey JL, et al. Pregnancy and the syndrome of herniated lumbar intervertebral disc: An epidemiological study. Yale J Biol Med 1975; 48: 361-8.
  pubmed

• 18. Bell GR, Rothman RH. The conservative treatment of sciatica. Spine 1984; 9: 54-6.
  pubmed

• 19. Hakelius A. Prognosis in sciatica: A clinical follow-up of surgical and non-surgical treatment. Acta Orthop Scand Suppl 1970; 129: 1-76.
  pubmed

• 20. Macnab I. Cervical spondylosis. Clin Orthop Relat Res 1975; 109: 69-77.
  pubmed

• 21. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 3rd edition. New York: Oxford University Press; 2001. p.628-49.

• 22. Tani T, et al. Electrophysiologic assessment of shoulder girdle weakness in patients with cervical spondylosis: Prognostic value of supraclavicular stimulation. J Clin Neuromus Dis 2002; 4: 11-8.

• 23. 柳 務ほか. Cervical spondylotic amyotrophy の臨床特徴. 臨床神経1976; 16: 520-8.

• 24. Keegan JJ. The cause of dissociated motor loss in the upper extremity with cervical spondylosis. J Neurosurg 1965; 23: 528-36.
  pubmed

• 25. 田中靖久ほか. 下垂指 (drop finger) を来す頚部神経根症. 臨整外2004; 39: 475-80.

• 26. Arnold JG. The clinical manifestation of spondylochondrosis (spondylosis) of the cervical spine. Ann Surg 1955; 141: 872-89.
  pubmed

• 27. Pavlov H, et al. Cervical spinal stenosis: Determination with vertebral body ratio method. Radiology 1987; 164: 771-5.
  pubmed

• 28. Tani T, et al. Age related shift in the primary sites of involvement in cervical spondylotic myelopathy from lower to upper levels. J Neurol Neurosurg Psychiatry 2002; 73: 316-8.

• 29. Tani T, et al. Functional importance of degenerative spondylolisthesis in cervical spondylotic myelopathy in the elderly. Spine 2003; 28: 1128-34.
  pubmed

• 30. Wisneski RJ, et al. Lumbar disc disease. In: Herkowitz HN, et al, editors. The Spine. Philadelphia: WB Saunders; 1999. p.613-79.

• 31. Dyck P, Doyle JB Jr. "Bicycle test" of van Gelderen in diagnosis of intermittent cauda equine compression syndrome. J Neurosurg 1977; 46: 667-70.

• 32. Tani T, et al. Sequential changes of orthodromic sensory nerve action potentials induced by experimental compression of the median nerve at the wrist. Clin Neurophysiol 2001; 112: 136-44.
  pubmed

• 33. Gasser HS, Erlanger J. The role of fiber size in the establishment of a nerve block by pressure or cocaine. Am J Physiol 1929; 88: 581-91.

• 34. Ochoa J, et al. Anatomical changes in peripheral nerves compressed by a pneumatic tourniquet. J Anat 1972
  pubmed

P.166 掲載の参考文献

• 1. 菊地臣一. いわゆる馬尾性間欠跛行. 日整会誌1988; 62: 567-75.

• 2. 菊地臣一. 腰部脊柱管狭窄の選択的除圧術. 臨整外1985; 20: 1180-90.

• 3. 紺野慎一ほか. 高齢者における腰部脊柱管狭窄の術後QOL. 臨整外2005; 40: 359-63.

• 4. Konno S, Kikuchi S. Prospective study of surgical treatment of degenerative spondylolisthesis: Comparison between decompression alone and decompression with Graf system stabilization. Spine 2000; 25: 1533-7

6章 高齢者の慢性骨髄炎

P.176 掲載の参考文献

• 1. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997; 336: 999-1007.
  pubmed

• 2. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364: 369-79.
  pubmed

• 3. 阿部哲士. 骨髄炎. 後藤 元, 斧 康雄編. 感染症クリニカルガイダンス. 東京: ヴァンメディカル; 2005. p.248-9.

• 4. 川嶌眞人ほか. 整形外科領域における感染症について. 日整会誌2005; 79: 221-7.

• 5. Norden C, et al. Evaluation of new anti-infective drugs for the treatment of infections of prosthetic hip joints. Clin Infect Dis 1992; 15 Suppl 1: S177-81.

• 6. Gold RH, et al. Bacterial osteomyelitis: Findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol 1991; 157: 365-70.
  pubmed

• 7. Kaim AH, et al. Imaging of chronic posttraumatic osteomyelitis. Eur Radiol 2002; 12: 1193-202.
  pubmed

• 8. Santiago Restrepo C, et al. Imaging of osteomyelitis and musculoskeletal soft tissue infections: Current concepts. Rheum Dis Clin North Am 2003; 29: 89-109.
  pubmed

• 9. 市川日出勝ほか. メチシリン耐性黄色ブドウ球菌 (MRSA) 骨髄炎に対する抗MRSA抗菌薬とホスホマイシンの併用療法の成績. 整形外科2004; 55: 505-8.

• 10. 阿部哲士ほか. MRSA骨髄炎に対する, 抗MRSA抗生剤とホスホマイシン (FOM) の併用化学療法. 日本骨・関節感染症研究会雑誌2004; 18: 139-41.

• 11. Mader JT, Calhoun J. General concept of osteomyelitis. In: Mandell GL, et al, editors. Principles and Practice of Infectious Diseases. 5th edition. Philadelphia: Churchill Livingstone; 2000. p.1182-96.

• 12. Cierny G, et al. A clinical staging system for adult osteomyelitis. Contemp Orthop 1985; 10: 17-37.

• 13. Lipsky BA, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39: 885-910.
  pubmed

• 14. Zimmerli W, et al. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-54.
  pubmed

• 15. Bernard L, et al. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 2004; 53: 127-9

7章 高齢者の周術期管理

P.185 掲載の参考文献

• 1. 厚生労働省. 平成17年度版 高齢社会白書. 第1章 高齢化の状況. 1 高齢化の現状と推移. 2005. http://www8.cao.go.jp/kourei/whitepaper/w-2005/zenbun/html/H1110000.html

• 2. Sieber PE, et al. Anesthesia for the elderly. In: Miller RD, editor. Miller's Anesthesia. 6th edition. Philadelphia: Elsevier Churchill Livingstone; 2005. p.2435-49.

• 3. Shock N. Systems integration. In: Finch CE, Hayflick L, editors. Handbook of the Biology of Aging. New York: Van Nostrand Reinhold; 1977. p.640.

• 4. Wahba WM. Influence of aging on lung function: Clinical significance of changes from age twenty. Anesth Analg 1983; 62: 764-76.
  pubmed

• 5. Kitamura H, et al. Postoperative hypoxemia: The contribution of age to maldistribution of ventilation. Anesthesiology 1972; 36: 244-52.
  pubmed

• 6. Leung JM, et al. Relative importance of preoperative health status versus intraoperative factors in predicting postoperative adverse outcomes in geriatric surgical patients. J Am Geriatr Soc 2001; 49: 1080-5.
  pubmed

• 7. Feldman C. Pneumonia in the elderly. Clin Chest Med 1999; 20: 563-73.
  pubmed

• 8. Muravchick S. Anesthesia for the elderly. In: Miller RD, editor. Miller's Anesthesia. 5th edition. Philadelphia: Elsevier Churchill Livingstone; 2000. p.2140-56.

• 9. Bernstein GM, Offenbartl SK. Adverse surgical outcomes among patients with cognitive impairments. Am Surg 1991; 57: 682-90.
  pubmed

• 10. Dripps RD, et al. The role of anesthesia in surgical mortality. JAMA 1961: 178: 261-6.
  pubmed

• 11. Tiret L, et al. Complications associated with anesthesia: A prospective study in France. Can Anaesth Soc J 1986; 33: 336-44.
  pubmed

• 12. 入田和男ほか. 「麻酔関連偶発症例1999」について-ASA-PS 別集計. 麻酔2001; 60; 678-91.

• 13. Cullen DJ, et al. ASA physical status and age predict morbidity after three surgical procedures. Ann Surg 1994; 220: 3-9.
  pubmed

• 14. Cohen MM, et al. Physical status score and trends in anesthetic complications. J Clin Epidemiol 1988; 41: 83-90.
  pubmed

• 15. Bailes BK. Perioperative care of the elderly surgical patient. AORN J 2000; 72: 186-207.
  pubmed

• 16. 日本呼吸器学会肺生理専門委員会編. 呼吸機能検査ガイドライン-スパイロメトリ, フローボリューム曲線, 肺拡散能力. 東京: メディカルレビュー社; 2004.

• 17. 厚生労働省. 平成16年 人口動態統計 (確定数) の概況. 結果の概要 第6表. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei04/hyo6.html

• 18. 山田達也ほか. 虚血性心疾患患者の非心臓手術の周術期管理に関する多施設共同調査-第1報. 麻酔2000; 49: 673-9.

• 19. 岩出宗代ほか. 虚血性心疾患患者の非心臓手術の周術期管理に関する多施設共同調査-第2報. 麻酔2000; 49: 796-801.

• 20. Eagle KA, et al. ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery. Circulation 2002; 105: 1257-67.
  pubmed

• 21. 中村真湖ほか. 静脈血栓症の最近の話題. 脈管学2003; 43: 121-6.

• 22. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. 東京: メディカルフロントインターナショナル; 2004.

• 23. 中村真湖. 周術期深部静脈血栓症. 瀬尾憲正編. 周術期の肺血栓塞栓症・深部静脈血栓症の予防と対策. 東京: 克誠堂出版;2004;p.3-17.

P.194 掲載の参考文献

• 1. 並木昭義, 土田英昭. 予定手術におけるリスクファクター. 稲田 豊ほか編. 麻酔前リスクファクターと対策. 東京: 克誠堂; 1990. p.312-8.

• 2. 小坂義弘. I. 麻酔前評価とインフォームド・コンセント. 岩崎 寛ほか編. 麻酔科診療プラクティス-よくある術前合 併症の評価と麻酔計画. 東京: 文光堂; 2002. p.2-5.

• 3. 入田和男ほか. 「麻酔関連偶発症例調査2000」について. ASA-PS別集計-日本麻酔学会手術室安全対策専門部会報告. 麻酔2002; 51: 71-85.

• 4. 奥津芳人. 低肺機能患者の術前評価と準備. 消化器外科1982; 5: 1137-44.

• 5. 諏訪邦夫. 肺機能検査. 臨床外科1991; 46: 545-50.

• 6. 野本幸子ほか. 低肺機能患者と術後肺合併症発生率. 麻酔1991; 40: 1210-7.

• 7. 岩崎 寛ほか. II. 麻酔に必要な術前の臓器評価の要点とリスク. 岩崎 寛ほか編. 麻酔科診療プラクティス-よくあ る術前合併症の評価と麻酔計画. 東京: 文光堂; 2002. p.8-42.

• 8. American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997; 127: 309-12.
  pubmed

• 9. Eagle KA, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: Report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 1996; 27: 910-48.

• 10. Eagle KA, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002; 105: 1257-67.

• 11. Goldman L, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 845-50.
  pubmed

• 12. Detsky AS, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1: 211-9.
  pubmed

• 13. Eagle KA, et al. Cardiac risk of noncardiac surgery: Influence of coronary disease and type of surgery in 3,368 operations. Circulation 1997; 96: 1882-7.

• 14. Mangano DT, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335: 1713-20.
  pubmed

• 15. Michalowski P, et al Specific consideration with liver disease. In: Hurford WE, et at, editors. Clinical Anesthesia Procedures of the Massachusetts General Hospital. 5th edition. Philadelphia: Lippincott-Raven; 1998. p.65-77.

• 16. Maze M, et al. Anesthesia and the hepatobiliary system. In: Miller RD, et at, editors. Anesthesia. 5th edition. Philadelphia: Churchill-Livingstone; 2000. p.1960-72.

• 17. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999; 29: 1617-23.
  pubmed

• 18. Ziser A, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90: 42-53.
  pubmed

• 19. 平澤博之ほか. 周術期の血液浄化法. 急性血液浄化法. 東京: 総合医学社; 1994. p.187-93.

• 20. Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-47.
  pubmed

• 21. MacKenzie CR, et al. Assessment of perioperative risk in the patient with diabetes mellitus. Surg Gynecol Obstet 1998; 167: 293-9.

• 22. Symreng T, et al. Physiological cortisol substitution of long-term steroid-treated patients undergoing major surgery. Br J Anaesth 1981; 53: 949-54.
  pubmed

P.201 掲載の参考文献

• 1. Stoddard MF, et al. Left ventricular diastolic function: Comparison of pulsed Doppler echocardiographic and hemodynamic indexes in subjects with and without coronary artery disease. J Am Coll Cardiol 1989; 13: 327-36.
  pubmed

• 2. 日本高血圧学会高血圧治療ガイドライン作成委員会. 高齢者高血圧. 高血圧治療ガイドライン2004. 東京: 日本高血圧学会; 2004. p.54-63.

• 3. Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth 2000; 86: 897-8.

• 4. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73: 413-67.
  pubmed

• 5. Ziegler MG, et al. Plasma noradrenaline increases with age. Nature 1976; 261: 333-5.
  pubmed

• 6. Muravchick S. Anesthesia for the elderly. In: Miller RD, editor. Anesthesia. 5th edition. Philadelphia: Churchill Livingstone; 2000. p.2140-56.

• 7. Sieber FE, Pauldine R. Anesthesia for the elderly. In: Miller RD, editor. Anesthesia. 6th edition. Philadelphia: Churchill Livingstone; 2005. p.2435-49.

• 8. Wynne HA, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.
  pubmed

• 9. 永山 敬ほか. 高齢者におけるセボフルランのMAC. 麻酔1994; 43: 238-41.

• 10. Stevens WC, et al. The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology 1971; 35: 8-16.
  pubmed

• 11. Schnider TW, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-16.
  pubmed

• 12. 矢島 直. 筋弛緩薬-ベクロニウム, パンクロニウム, サクシニルコリン. 花岡一雄, 大内尉義編. 高齢者の病態生理と麻酔の臨床. 東京: 真興交易医書出版部; 2003. p.155-63.

• 13. Lien CA, et al. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg 1991; 73: 39-42.
  pubmed

• 14. 香月 博, 高崎眞弓. 局所麻酔薬. 花岡一雄, 大内尉義編. 高齢者の病態生理と麻酔の臨床. 東京: 真興交易医書出版部; 2003. p.144-54.

• 15. Vaughan MS, et al. Postoperative hypothermia in adults: Relationship of age, anesthesia, and shivering to rewarming. Anesth Analg 1981; 60: 746-51.
  pubmed

• 16. Kurz A, et al. The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in the elderly than young patients. Anesthesiology 1993; 79: 465-9.
  pubmed

• 17. Vassilieff N, et al. Shivering threshold during spinal anesthesia is reduced in the elderly patients. Anesthesiology 1995; 83: 1162-6.
  pubmed

• 18. Frank SM, et al. Unintentional hypothermia is associated with postoperative myocardial ischemia. The Perioperative Ischemia Randomized Anesthesia Trial Study Group.Anesthesiology 1993; 78: 468-76.

• 19. Schmied H, et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347: 289-92.
  pubmed

• 20. Sheffield CW, et al. Mild hypothermia during isoflurane anesthesia decreases resistance to E. coli dermal infection in guinea pigs. Acta Anaesthesiol Scand 1994; 38: 201-5.

P.211 掲載の参考文献

• 1. Iagawa G, et al. A comparison of five techniques for detecting cardiac activity in infants. Paediatr Anaesth 2003; 13: 141-6.

• 2. Sebel PS. Central nervous system monitoring during open heart surgery: An update. J Cardiothorac Vasc Anesth 1998; 12 (2) : 3-8.

• 3. Sleigh JW, et al. Comparison of bispectral index, 95% spectral edge frequency and approximate entropy of the ECG, with changes in heart rate variability during induction of general anesthesia. Br J Anesth 1999; 82: 666-71.

• 4. Glass P, et al. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane and alfentanil in healthy volunteers. Anesthesiology 1997; 86: 836-47.
  pubmed

• 5. Thomas M, et al. Monitoring of the cardiac patient. In: Hensley FA, et al, editors. A Practical Approach to Cardiac Anesthesia. 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2003. p.98-140.

• 6. Hillel ZH, et al. Electrocardiography. In: Miller RD, et al, editors. Anesthesia. 5th edition. New York: Churchill Livingstone; 2000. p.1231-54.

• 7. Brath PC, et al. Electrocardiographic monitoring for ischemia and arrhythmia. In: Lake CI, et al, editors. Clinical Monitoring: Practical Application for Anesthesia and Critical Care. Philadelphia: WB Saunders; 2001. p.149-80.

• 8. Matthys K, et al. Development and modelling of arterial applanation tonometry. Technol Health Care 2002; 10: 65-76.
  pubmed

• 9. Keenan Sp.Use of ultrasound to place central lines. J Crit Care 2002; 17: 126-37.

• 10. Fallat R. Getting the blood out of blood gas studies. Respir Ther 1982; 12: 103-4.

• 11. 三島史郎ほか. 尿化学と腎機能. 救急医学2001; 25: 1215-20.

• 12. Frank SM, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. JAMA 1997; 277: 1127-34

• 13. 本多夏生. 高体温が生体に及ぼす影響について. 日臨麻酔会誌1995; 15: 187-95.

• 14. Shapiro BA, et al. Respiratory care. In: Miller RD, editor. Anesthesiology. 5th edition. Philadelphia: Churchill Livingstone; 2000. p.2403-42.

P.218 掲載の参考文献

• 1. Bernard JM, et al. Long-term hypotensive technique with nicardipine and nitroprusside during isoflurane anesthesia for spinal surgery. Anesth Analg 1992; 75: 179-85.
  pubmed

• 2. Porter SS, et al. Comparison of intravenous nitroprusside, nitroprusside-captopril, and nitroglycerin for deliberate hypotension during posterior spine fusion in adults. J Clin Anesth 1988; 1: 87-95.
  pubmed

• 3. Ozier Y, Schlumberger S. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient. Can J Anaesth 2006; 53 (6 Suppl) : S21-9.

• 4. Franchini M, et al. Preoperative autologous blood donation in primary total knee arthroplasty: A single-centre experience on 214 consecutive patients. Vox Sang 2006; 90: 191-4.
  pubmed

• 5. Endoh H, et al. Effects of nicardipine-, nitroglycerin-, and prostaglandin E1-induced hypotension on human cerebrovascular carbon dioxide reactivity during propofol-fentanyl anesthesia. J Clin Anesth 1999; 115: 45-9.

• 6. 多保悦夫ほか. 低血圧麻酔に用いる降圧薬は何が最良か?-術中の肝腎血流および術後の肝腎機能を指標としての検討. 麻酔2000; 49: 1333-8.

• 7. Sharrock NE, et al. Deliberate hypotensive epidural anesthesia for patients with normal and low cardiac output. Anesth Analg 1994; 79: 899-904.
  pubmed

• 8. Hatzidakis AM, et al. Preoperative autologous donation for total joint arthroplasty: An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am 2000; 82: 89-100.
  pubmed

• 9. Jaffer AK, et al. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty. Mayo Clin Proc 2005; 80: 732-8

P.227 掲載の参考文献

• 1. Kevin AB, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005; 112: I-286-92.

• 2. Geerts WH, et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S.
  pubmed

• 3. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. 東京: メディカルフロントインターナショナル; 2004.

• 4. Hirst AE, et al. Myocardial infarction and pulmonary embolism. Arch Pathol 1960; 80: 365-7.

• 5. 平井正文. わが国における動向-サーベランスデータをもとに. 特集深部静脈血栓症の背景を探る. 血栓と循環2003; 11: 24-8.

• 6. 藤田 悟ほか. 股関節または膝関節全置換術術後における深部静脈血栓および肺塞栓症の発生頻度-予見的多施設共同研究. 整形外科2000; 51: 745-9.

• 7. Taylor FB Jr, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation: On behalf of the scientific subcommittee on disseminated intravascular coagulation (DIC) of the international societyon thrombosis and haemostasis (ISTH). Thromb Haemost 2001; 86: 1327-30.

P.232 掲載の参考文献

• 1. Watters JM. Surgery in the elderly. Can J Surg 2002; 45: 104-8.
  pubmed

• 2. Rosenthal RA. Kavic SM. Assessment and management of the geriatric patient. Crit Care Med 2004; 32: S92-105.
  pubmed

• 3. Mangano DT, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.N Engl J Med 1996; 335: 1713-20.

• 4. Eagle KA, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery. Circulation 2002; 105: 1257-67.
  pubmed

• 5. Chen J, et al. Effectiveness of β-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 2001; 37: 1950-6.

• 6. Schouten O, et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study. Am Heart J 2004; 148: 1047-52.
  pubmed

• 7. Hogue CW, et al. Swallowing dysfunction after cardiac operations: Associated adverse outcomes and risk factors including intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg 1995; 110: 517-22.
  pubmed

• 8. Rousou JA, et al. Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg 2000; 69: 486-9.
  pubmed

• 9. Cheatham ML, et al. Meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg 1995; 221: 469-76.
  pubmed

• 10. Frank SM, et al. Unintentional hypothermia is associated with postoperative myocardial ischemia. The Perioperative Ischemia Randomized Anesthesia Trial Study Group.Anesthesiology 1993; 78: 468-76.

• 11. Frank SM, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events: A randomized clinical trial. JAMA 1997; 277: 1127-34.
  pubmed

• 12. Dhar p.Managing perioperative hypothermia. J Anesth 2000; 14: 91-7.
  pubmed

• 13. Kurz A, et al. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group.N Engl J Med 1996; 334: 1209-15.

• 14. Best WR, et al. Identifying patient preoperative risk factors and postoperative adverse events in administrative databases: Results from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Am Coll Surg 2002; 194: 257-66.

• 15. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. 東京: メディカルフロントインターナショナル; 2004.

P.240 掲載の参考文献

• 1. Grass JA. The role of epidural anesthesia and analgesia in postoperative outcome. Anesthesiol Clin North America 2000; 18: 407-28.
  pubmed

• 2. 村川和重ほか. 整形外科領域の術後鎮痛. ペインクリニック2003; 24: 183-93.

• 3. Woolf CJ, Chong MS. Preemptive analgesia: Treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362-79.
  pubmed

• 4. 林田眞和ほか. 術後疼痛の生体内に及ぼす影響. ペインクリニック2003; 24: 14-8.

• 5. Ready BL. Acute postoperative pain. In: Miller RD, et al, editors. Anesthesia. 4th edition. New York: Churchill Livingstone; 1994. p.2327-44.

• 6. Modig J, et al. Thromboembolism after total hip replacement: Role of epidural and general anesthesia. Anesth Analg 1983; 62: 174-80.
  pubmed

• 7. Scott LE, et al. Examining the interaction effects if coping style and brief interventions in the treatment of postsurgical pain. Pain 1984; 20: 279-91.
  pubmed

• 8. Niemi G, et al. Epinephrine markedly improves thoracic epidural analgesia produced by a small-dose infusion of ropivacaine,fentanyl, and epinephrine after major thoracic or abdominal surgery: A randomized, double-blinded crossover study with and without epinephrine. Anesth Analg 2002; 94: 1598-605.
  pubmed

• 9. Urban MK, et al. Reduction in postoperative pain after spinal fusion with instrumentation using intrathecal morphine. Spine 2002; 27: 535-7.
  pubmed

• 10. Toivonen J, et al. Comparison between intra-articular bupivacaine with epinephrine and epinephrine alone on short-term and long-term pain after knee arthroscopic surgery under general anesthesia in day-surgery patients. Acta Anaesthesiol Scand 2002; 46: 435-40.
  pubmed

• 11. Laurila PA, et al. Interscalene brachial plexus block is superior to subacromial bursa block after arthroscopic shoulder surgery. Acta Anaesthesiol Scand 2002; 46: 1031-6.
  pubmed

• 12. Lennox PH, et al. A continuous perineural infusion of local anesthetic provides effective postoperative pain management after lower limb amputation. Can J Anaesth 2002; 49: 639-40.
  pubmed

• 13. 佐伯 茂. 鎮痛剤の薬物相互作用. ペインクリニック2005; 26: 1229-38.

• 14. 斉藤泰一. 薬理学総論. エッセンシャル薬理学. 東京: 医歯薬出版; 1998. p.1-45.

• 15. Edwards IR. Medicine adverse reactions commitee: Eighteenth annual report. N Z Med J 1984; 97: 729-32.

• 16. 柳浦才三ほか. アスピリンの薬理学的配合禁忌. 薬局1984; 35: 715-22.

• 17. Walker AM, et al. Predictors of bleeding during heparin therapy. JAMA 1980; 244: 1209-12.
  pubmed

• 18. Mathews A, Bailie GR. Acute renal failure and hyperkalemia associated with triamterene and indomethacin. Vet Hum Toxicol 1986; 28: 224-5.
  pubmed

• 19. Hiraga K, et al. Pharmacokinetics of morphine suppository (ANPEC) alone or combined with diclofenac sodium suppository. Pain Research 1992; 7: 165-70.

P.247 掲載の参考文献

• 1. 大森貴夫ほか. 高齢者大腿骨頚部骨折患者における術前動脈血ガス分析と術後肺合併症の検討. 骨折2004; 26: 47-50.

• 2. 大長省博ほか. 高齢者の大腿骨頚部骨折における術後早期死亡例の検討. 整形外科と災害外科2003; 52: 406-10.

• 3. Freiman DG, et al. Frequency of pulmonary thromboembolism in man. N Engl J Med 1965; 272: 1278-80.

• 4. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドラインダイジェスト版. 第2版. 東京: メディカルフロントインターナショナルリミテッド; 2004.

• 5. 松田圭二ほか. 股関節および膝関節手術における術後血栓塞栓症の予防療法. 別冊整形外科2001; 40: 242-8.

• 6. 松田圭二ほか. 下肢関節手術後の血栓塞栓術の危険因子と予防療法. 整形外科と災害外科2001; 44: 1195-202.

• 7. Monreal M, et al. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications of coumarin. Thromb Haemost 1994; 71: 7-11.
  pubmed

• 8. Stulberg BN, et al. Deep-vein thrombosis following total knee replacement: An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am 1984; 66: 194-201.
  pubmed

• 9. 国枝武義. 肺塞栓症診療のポイント-どんなとき疑い, 予防, 初期治療をどう行うか. 東京: 医学書院; 2002.

• 10. 木村理夫ほか. 肺血栓塞栓症6例の治療経験. 整形外科1998; 49: 21-5.

• 11. 柳浦敬子ほか. 超高齢者の大腿骨頚部骨折, 術前及び術後の合併症について. 中部整災誌2002; 45: 809-10.

8章 高齢者のリハビリテーション

P.257 掲載の参考文献

• 1. World Health Organization. International Classification of Impairments, Disabilities and Handicaps (ICIDH). Geneva: World Health Organization; 1980.
  pubmed

• 2. Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chron Dis 1970; 23: 455-68.
  pubmed

• 3. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 2nd edition. Philadelphia: FA Davis; 1989. p.95-7.

• 4. Brunnstrom S. Motor testing procedures in hemiplegia: Based on sequential recovery stages. Phys Ther 1966; 46: 357-75.
  pubmed

• 5. Chino N, et al. Stroke impairment assessment set (SIAS). In: Functional Evaluation of Stroke Patients. Tokyo: Springer-Verlag; 1996. p.19-31.

• 6. 千野直一ほか. 脳卒中患者の機能評価-SIASとFIMの実際. 東京: シュプリンガー・フェアラーク東京; 1997.

• 7. 立野勝彦. 中枢性麻痺の評価. 米本恭三ほか編. リハビリテーションにおける評価. 東京: 医歯薬出版; 1996. p.18.

• 8. 千野直一編. 現代リハビリテーション医学. 東京: 金原出版; 1999. p.336.

• 9. 道免和久. 脳卒中片麻痺患者の機能評価法Stroke Impairment Assessment Set (SIAS) の信頼性および妥当性の検討. (1) 麻痺側運動機能, 筋緊張, 腱反射, 健側機能. リハ医学1995; 32: 113-22.

• 10. 赤星和人ほか. Fugl-Meyer評価法による脳血管障害総合的身体機能評価に関する検討. リハ医学1992; 29: 131-6.

• 11. Bohannon RW, et al. Interrater reliability of modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-7.
  pubmed

• 12. 渡邊義文. うつ病. 日医雑誌特別号2004; 131: s132-5.

• 13. 仲田和正. 老人姿勢の研究. 日整会誌1988; 62: 1149-61.

• 14. Murray MP, et al. Walking patterns in health old men. J Gerontol 1969; 24: 169-78.

• 15. 大高洋平, 里宇明元. 高齢者の姿勢と歩行. 老年精医誌2005; 16: 922-8.

• 16. Nutt JG, et al. Human walking and higher-level gait disorders, particularly in the elderly. Neurology 1993; 43: 268-79.
  pubmed

• 17. Yim-Chiplis PK, Talbot LA. Defining and measuring balance in adults. Biol Res Nurs 2000; 1: 321-31.
  pubmed

• 18. Berg KO, et al. Clinical and laboratory measures of postural balance in an elderly population. Arch Phys Med Rehabil 1992; 73: 1073-80.

• 19. Podsiadlo D, Richardson S. The timed "up and go" : A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142-8.

• 20. 永田雅章. 歩行障害. 千野直一ほか編. リハビリテーション診断・評価. 東京: 金原出版; 2000. p.157-65.

• 21. 日本リハビリテーション医学会. ADL評価について. リハ医学1976; 13: 315.

• 22. Lawton MP, et al. Assessment of older people: Self-maintaining and instructional activities of daily living. Gerontlogist 1969; 9: 179-86.

• 23. 伊藤利之. 生活関連動作 (活動) の概念と評価. 総合リハ1994; 22: 543-7.

• 24. 里宇明元. ADL・IADL・QOLとは. 千野直一ほか編. ADL・IADL・QOL. 東京: 金原出版; 2004. p.1-22.

• 25. 池上直己ほか編. 臨床のためのQOLハンドブック. 東京: 医学書院; 2001. p.2-7.

• 26. 佐久間真由美, 遠藤直人. JOQOL. 骨粗鬆症治療2004; 3: 122-7.

• 27. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J 1965; 14; 61-5.
  pubmed

• 28. 千野直一監訳. FIM-医学的リハビリテーションのための統一データセット利用の手引き. 原書第3版. 東京: 慶應義 塾大学医学部リハビリテーション科; 1991.

• 29. Yamada S, et al. Development of a short version of the motor FIM for use in long-term care settings. J Rehabil Med 2005; 37: 1-8.

• 30. Sainsbury A, et al. Reliability of the Barthel index when used with older people. Age Aging 2005; 34: 228-32.
  pubmed

• 31. Masedo AI, et al. Reliability and validity of a self-report FIM (FIM-SR) in persons with amputation or spinal cord injury and chronic pain. Am J Phys Med Rehabil 2005; 84: 167-76.
  pubmed

• 32. 古谷野 亘ほか. 地域老人における活動能力の測定-老研式活動能力指標の開発. 日公衛誌1987; 34: 109-14.

• 33. Holbrook M, et al. An activities index for use with stroke patients. Age Aging 1983; 12: 166-70.
  pubmed

• 34. 白土瑞穂ほか. 日本語版 Frenchay Activities Index 自己評価表およびその臨床応用と標準値. 総合リハ1999; 27: 469-74.

• 35. 蜂須賀研二ほか. 応用的日常生活動作と無作為抽出法を用いて定めた在宅中高齢者の Frenchay Activities Index 標準値. リハ医学2001; 38: 287-95.

• 36. 千野直一編. 現代リハビリテーション医学. 東京: 金原出版; 1999. p.534-5.

• 37. 尾藤誠司, 福原俊一. Short Form 36 Health Survey (SF-36) 面接用バージョンの妥当性, および施設入所老人と一般在宅老人との比較を中心とした高齢者Health-Related Quality of Life 測定の試み. 日老医会誌1998; 35: 458-63.

• 38. Hayes V, et al. The SF-36 health survey questionnaire: Is it suitable for use with older adults ? Age Aging 1995; 24; 120-5.
  pubmed

• 39. Silverman SL. The osteoporosis assessment questionnaire (OPAQ) : A reliable and valid disease-targeted measure of health-related quality of life (HRQOL) in osteoporosis. Qual Life Res 2000; 9: 767-74.

• 40. Lips P, Leplege A. Development and validation of a quality of life questionnaire for patients with vertebral fractures: Qualeffo-41. Qual Life Res 2000; 9: 763-6.

• 41. 高橋栄明ほか. 骨粗鬆症患者のQOL評価質問表-1999年度版の試用と2000年度版の作成. 日骨代謝誌2001; 18: 83-101.

• 42. 問川博之ほか. 脳卒中特異的QOLスケールに関する検討. 臨床リハ2005; 14: 684-9.

• 43. Yoh K, et al. Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatnin treatment. J Bone Miner Metab 2005; 23: 167-73.
  pubmed

• 44. 宮腰尚久. 骨粗鬆症性脊椎椎体骨折に伴うADL・QOL障害. MB Orthop 2005; 18: 7-15.

• 45. 山田 深, 里宇明元. 仮の要介護状態とその対策. リハ医学2005; 42: 690-6.

P.266 掲載の参考文献

• 1. 内閣府共生社会対策統括官. 高齢社会対策に関する調査. 高齢者の日常生活に関する意識調査. 東京: 内閣府; 2004.

• 2. 厚生労働省. 平成16年度国民生活基礎調査. 要介護者等の状況. 東京: 厚生労働省; 2005.

• 3. 中村隆一. リハビリテーションの過程. 中村隆一編. リハビリテーション概論. 第2版増補. 東京: 医歯薬出版; 1996. p.91-102.

• 4. 眞野行生. リハビリテーション医療のあらまし. 米本恭三監. 最新リハビリテーション医学. 東京: 医歯薬出版; 1999. p.10-21.

• 5. 豊倉 穣ほか. リハビリテーション医療の急性期・回復期・維持期. 米本恭三監. 最新リハビリテーション医学. 改定第2版. 東京: 医歯薬出版; 2005. p.11-7.

• 6. Hirschberg GG, et al. Rehabilitation. Philadelphia: Lippincott; 1964. p.12-23.

• 7. 里宇明元. 併存疾患のとらえかた. 臨床リハ (別冊) 脳卒中リハビリテーション外来診療. 東京: 医歯薬出版; 1997. p.45-9.

• 8. 鳥羽研二. 老年症候群. 日本老年医学会編. 老年医学テキスト. 東京: メジカルビュー; 2002. p.98-103.

• 9. 朝比奈朋子. 高齢者骨関節外傷リハビリテーションへの社会的視点からのアプローチと支援. MB Med Rehabil 2005; 59: 60-7.

• 10. 吉永勝訓. 変形性膝関節症. 臨床リハ2002; 11: 601-7.

• 11. Stitik Tp.Osteoarthritis. In: DeLisa JA, et al, editors. Physical Medicine and Rehabilitation: Principle and Practice. Philadelphia: Lippincott Williams & Wilkins; 2004. p.765-86.

• 12. 日本整形外科学会診療ガイドライン委員会, 大腿骨頚部/転子部骨折ガイドライン策定委員会, 厚生労働省医療技術評価総合研究事業「大腿骨頚部骨折の診療ガイドライン作成」班編. 大腿骨頚部骨折/転子部骨折診療ガイドライン. 東京: 南江堂; 2005.

• 13. 原 行弘. 大腿骨頚部骨折. 千野直一ほか編. リハビリテーション Mook13 高齢者のリハビリテーション. 東京: 金原出版; 2005. p.199-208.

• 14. 山崎 薫ほか. 高齢者大腿骨頚部骨折のリハビリテーション. 臨床リハ 2003; 12: 308-14.

• 15. 浅山 滉. リハビリテーションから第一線治療への注文. 臨床リハ2003; 12: 315-20.

• 16. 陳 隆明. 高齢下肢切断者のリハビリテーションゴールの設定と義足処方. MB Med Rehabil 2002; 16: 31-8.

• 17. 赤居正美. リハビリテーション効果と予後. 総合リハ2005; 33: 235-9.

• 18. 問川博之. 高齢者の頚髄損傷. 千野直一ほか編. リハビリテーション Mook13 高齢者のリハビリテーション. 東京: 金原出版; 2005. p.176-89.

• 19. 平澤泰介. 高齢者の関節痛のとらえかた. 臨床リハ2002; 11: 594-600.

• 20. 竹原 格ほか. リハビリテーションにおける事故防止. 東京: メジカルビュー; 2006. p.173-7.

9章 高齢者医療と保健・福祉

P.277 掲載の参考文献

• 1. 厚生統計協会. 国民の福祉の動向2006年. 東京: 厚生統計協会; 2006.

• 2. 高齢者ケア・ガイドブック編集委員会. 高齢者ケア・ガイドブック (加除式). 東京: 中央法規; 2006.

• 3. Williams ME. The American Geriatrics Society's Complete Guide to Aging & Health. New York: Harmony Books; 1995.

P.283 掲載の参考文献

• 1. 遠藤英俊. 在宅介護の問題点. 日本老年医学会雑誌 1997; 34 (12) : 987-9.

• 2. 厚生労働省高齢者ケアサービス体制整備検討委員会編. 介護支援専門員標準テキスト, 第1巻. 東京: 長寿社会開発セ ンター; 2006.

• 3. 遠藤英俊. かかりつけ医の意見書と介護支援専門員の役割. 総合ケア 1998; 8 (7) : 42-6.
  Medical*Online

• 4. 遠藤英俊. ケア担当者会議すすめかた. 大田仁史ほか編. 別冊総合ケア. 介護支援専門員4. 東京: 医歯薬出版; 2000. p.8-39.

• 5. 遠藤英俊. ケアマネジメントにおけるパソコンの活用. 日経メディカル 1997; 11: 36-8.

• 6. 遠藤英俊. 介護保険の改訂への提言. 老年精神医学雑誌 2001; 12 (5) : 492-5.
  Medical*Online

• 7. 遠藤英俊. 要介護認定マニュアル. 東京: 医歯薬出版; 2006.

P.287 掲載の参考文献

• 1. 厚生労働省. 平成17年度介護保険事業報告. http://www.mhlw.go.jp/

• 2. 厚生労働省. 介護保険制度改革の概要-介護保険法改正と介護報酬改定. 東京: 厚生労働省老健局総務課; 2006.

• 3. Omori G. Epidemiology of knee osteoarthritis. Acta Medica et Biologica 2005; 53: 1-11.

• 4. 厚生労働省. 平成16年度国民生活基礎調査. http://www.mhlw.go.jp/

• 5. Shaw WS, et al. Emotional expressiveness, hostility and blood pressure in a longitudinal cohort of Alzheimer caregivers. J Psychosom Res 2003; 54: 293-302.

• 6. Kiecolt-Glaser JK, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 2003; 100: 9090-5.
  pubmed

• 7. Schulz R, et al. End-of-life care and the effects of bereavement on family caregivers of persons with dementia. N Eng J Med 2003; 349: 1936-42.

• 8. Schulz R, Beach SR. Caregiving as a risk factor for mortality. JAMA 1999; 282: 2215-9.
  pubmed

• 9. Zarit SH, et al. Relatives of the impaired elderly: Correlates of feelings of burden. Gerontologist 1980; 20: 649-55.
  pubmed

• 10. Zarit SH, et al. The Memory and Behaviour Problems Checklist 1987R and the Burden Interview. Pennsylvania State University Gerontology Center: University Park; 1990.

• 11. Arai Y, et al. Reliability and validity of the Japanese version of the Zarit Caregiver Burden Interview. Psychiatry Clin Neurosci 1997; 51: 281-7.
  pubmed

• 12. 荒井由美子ほか. Zarit 介護負担尺度日本語版の短縮版 (J-ZBI_8) の作成-その信頼性と妥当性に関する検討. 日老医誌2003; 40: 471-7.

• 13. Kumamoto K, Arai Y. Validation of "Personal Strain" and "Role Strain" : Subscales of the short version of the Japanese version of the Zarit Burden Interview (J-ZBI_8). Psychiatry Clin Neurosci 2004; 58: 606-10.
  pubmed

• 14. 熊本圭吾, 荒井由美子. 日本語版Zarit介護負担尺度短縮版 (J-ZBI_8) の交差妥当性の検討. 日老医誌2004; 41: 204-10.

• 15. Arai Y, et al. Are there inequities in the assessment of dementia under Japan's LTC insurance system? Int J Geriatr Psychiatry 2003; 18: 346-52. 高齢者を介護する家族の負担287

• 16. Arai Y, Washio M. Burden felt by family caring for the elderly members needing care in southern Japan. Aging Ment Health 1999; 3: 158-64.

• 17. Arai Y, et al. Factors related to feelings of burden among caregivers looking after impaired elderly in Japan under the Long-Term Care Insurance system. Psychiatry Clin Neurosci 2004; 58: 396-402.

• 18. Zarit SH, et al. Subjective burden of husbands and wives as caregivers: A longitudinal study. Gerontologist 1986; 26: 260-6.
  pubmed

• 19. Arai Y, et al. Patterns of outcome of caregiving for the impaired elderly: A longitudinal study in rural Japan. Aging Ment Health 2002; 6: 39-46.
  pubmed

• 20. Schiamberg L, Gans D. Elder abuse by adult children: An applied ecological framework for understanding contextual risk factors and the intergenerational character of quality of life. Int J Aging Hum Dev 2000; 50: 329-59.
  pubmed

• 21. 新田順子, 荒井由美子. 訪問看護師から見た介護者の介護負担の実態. 日老医誌2005; 42: 181-5.

• 22. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 1966; 44: 166-206.

• 23. 荒井由美子ほか. 在宅ケアの質評価法 (Home Care Quality Assessment Index: HCQAI) の開発. 日老医誌2005; 42: 432-43.

• 24. 熊本圭吾, 荒井由美子. 在宅ケアの質評価法Home Care Quality Assessment Index: HCQAI の妥当性の検証. 日老医誌 2006; 43: 518-24.

• 25. 荒井由美子ほか. 国立長寿医療センター方式訪問看護データベース入力支援システムの開発. 日本医事新報2006; 4285: 69-73.

• 26. Miller B, et al. Social support and caregiver distress: A replication analysis. J Gerontol B-Psychol Sci Soc Sci 2001; 56: S249-56.
  pubmed

• 27. Kumamoto K, et al. Use of home care services effectively reduces feelings of burden among family caregivers of disabled elderly in Japan: Preliminary results. Int J Geriatr Psychiatry 2006; 21: 163-70 .
  pubmed

• 28. Gillespie LD, et al. Interventions for preventing falls in elderly people Cochrane Review. Cochrane Database of Systematic Reviews. 4, 2006.

• 29. Hebert R, et al. Efficacy of a psychoeducative group program for caregivers of demented persons living at home: A randomized controlled trial. J Gerontol BPsychol Sci Soc Sci 2003; 58: S58-67.